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ABSTRACT 
The global market for the medical diagnostic industry is worth 25 billion dollars in the 
United States and is expected to grow exponentially each year. Presently available 
methods for biodetection, such as immunoassays, chemiluminescence and fluorescent 
based assays are expensive, time consuming and require skilled labor with high-end 
instruments. Therefore, development of novel, passive colorimetric sensors and 
diagnostic technologies for detection and surveillance is of utmost importance especially 
in resource constrained communities.  
 The present work focusses on developing novel and advanced in vitro 
biodiagnostic tools based on aptamer integrated biosensors for an early detection of 
specific viral proteins or small biomolecules used as potential markers for deadly 
diseases. Aptamers are short single stranded deoxyribonucleic acid (DNA) which are 
designed to bind to a specific target biomolecule. These are readily synthesized in 
laboratory and offers several advantages over antibodies/enzymes such as stable in 
harsh environment, easily functionalized for immobilization, reproducibility etc. These 
undergo conformational changes upon target binding and produces physical or chemical 
changes in the system which are measured as colorimetric or electrochemical signals. 
Here, we have explored the aptamer-analyte interaction on different platforms such as 
microfluidic channel, paper based substrate as well as organic electrochemical transistor 
to develop multiple compact, robust and self-contained diagnostic tools. These testing 
tools exhibit high sensitivity (detection limit in picomolar) and selectivity against the target 
molecule, require no sophisticated instruments or skilled labor to implement and execute, 
leading a way to cheaper and more consumer driver health care. These innovative 
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platforms provide flexibility to incorporate additional or alternative targets by simply 
designing aptamers to bind to the specific biomolecule. 
 
Keywords: Aptamers, point-of-care diagnostics, Organic electrochemical transistor, 
microfluidics, epinephrine, Zika, Chikungunya, Gold nanoparticles, PDMS. 
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CHAPTER 1: INTRODUCTION 
1.1 Introduction to Biosensors 
 
In the recent decade, the development of Point of care (POC) diagnostics has garnered 
tremendous amount of attention due to its applications in the early diagnosis of diseases 
which can be extremely helpful in the health care industry. The factors such as lack of 
trained personnel, well-equipped centers and cost of biosensors are the some of the 
obstacles which limit the use of diagnostic tools in the third world countries. WHO has 
defined an idealistic biosensor to an ASSURED device which stands for Affordable, 
Sensitive, Specific, User-friendly, Rapid and Robust, Equipment-free and Deliverable [1-
3].  
 In vitro point of care testing refers to the examination of reagents such as bodily 
fluids, tissues, cells etc using a combination of techniques, reagents or instruments with 
the goal of detecting an analyte in a controlled environment outside living organism 
(Figure 1). These devices offer the opportunity to perform the assay at the patient’s site 
and obtain results rapidly and accurately with a limited infrastructure. The rapid testing 
results in better patient management, reduces multiple visits, enable timely treatment and 
more importantly, contain infectious disease. It has been reported that the successful 
implementation of a 90% sensitive malaria POC testing device has the ability to prevent 
unnecessary treatment worth of 450 million and save over 2.2 million lives. Testing 
techniques with higher sensitivity but with minimal laboratory requirements will prevent 
only 400 million unnecessary treatments. The potential of POCs to provide clinically 
2 
 
relevant information without the need for a laboratory setting or trained personal has 
fueled the demand to generate new tools to diagnose broad spectrum of biomolecules. 
From the research point of view, more than 73000 search items are displayed, when the 
keywords “point of care” are searched in PubMed [4].  
 
 
Figure 1: Multiplexed Point of Care Testing [5] 
 The demand for POC diagnostics has skyrocketed in recent years. The global in 
vitro diagnostic market share has been estimated to exceed USD 70 billion by 2022 
according to Market search engine [6]. The major challenge is to bring the techniques to 
patient’s site without compromising the sensitivity or accuracy of the approach. Figure 1 
shows a schematic of a general multiplex POC testing where the blood is taken from an 
individual, run and analyzed on a platform and the output signal is displayed on a smart 
phone device. The platforms range from microfluidic channel, paper based sensors, use 
of nanosized beads and plate based assays. The current available biosensors are 
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categorized on the basis of processes that translates the binding event into an output 
readable signal. The next section explains different types of biosensor based on the 
output signal that are available today.  
 
1.2 Types of sensors 
1.2.1 Colorimetric sensor 
Metal nanoparticles exhibit unique size and shape dependent optical properties [7-12]. A 
strong absorption band is observed in the UV-Visible spectra of the gold and silver 
metallic nanoparticles when light is incident on them. This band is due to the interaction 
of light with metal nanoparticles which results in collective oscillation of the electrons in 
the conduction band and gives rise to strong surface plasmon resonance (SPR) signal 
[13-15]. The SPR signal is highly dependent on the surface morphology of the material, 
therefore any change in size, shape or the dielectric properties of the surrounding medium 
will cause a shift in the electron density. This results in a change in the oscillation 
frequency, generating different absorption and scattering spectrum. Typically for gold 
nanoparticles smaller than 20 nm, the SPR band is seen at 520 nm which is in the range 
of visible range as shown in Figure 2. Therefore, any shift in the absorption plasmon band 
due to change in the morphology is visible through naked eyes without any external 
excitation or emission source.[16] Figure 2B represents different colors of gold 
nanoparticles which can be synthesized by varying the size. The UV-Visible spectra 
shows the red shift with increasing size of gold nanoparticles. It can be seen that varying 
the size of AuNPs from 10-100 nm causes red shift in the absorption spectrum from 520 
to 580 nm (Figure 2A). These unique size-dependent optical properties of AuNPs along 
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with high extinction coefficient and high surface-to-volume has made them ideal 
candidate in sensing applications.  
 
Figure 2: (A) Normalized absorbance of Gold nanoaprticles (AuNPs) with different sizes. 
(B) Red-shift in the SPR peak with increasing diameter of AuNPs. Inset shows different 
colored AuNPs with different sizes [16]  
 
 Target induced specific aggregation of the AuNPs has gained much attention in 
recent decades in the detection and imaging world of biological targets. The surface of 
the AuNPs can be easily functionalized with an acceptor molecule which shows high 
affinity towards a specific target. For example, AuNPs functionalized with biotin shows 
high affinity towards streptavidin. Exposure of these functionalized AuNPs to streptavidin 
will induce agglomeration in the solution changing the color of the solution from red to 
blue. This color change is due to the shifting of maximum SPR peak to longer wavelengths 
(red shift). Antibodies and DNA strands have been widely used as biorecognition 
elements to detect the presence of small molecules, proteins or other nucleic acid. The 
role of these elements is two fold- first is to specifically bind to the molecule and second 
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is to provide stability to the AuNPs and protect them against salt aggregation. The 
detection of DNA strand is done by functionalizing the surface with a single stranded (ss) 
DNA. In the presence of the complimentary strand, the ssDNA strand is released leaving 
the AuNPs surface exposed eventually leading to aggregation [17]. The similar approach 
has been used for the detection of dopamine, thrombin and cocaine [18, 19] in which the 
surface of AuNPs is functionalized with DNA designed for the specific target molecule.  
 
 
Figure 3: Schematic showing mechanism behind colorimetric detection of metal ions 
using AuNPs. (A) The presence of metal ions causes AuNPs to aggregate and change 
the color from red to blue. (B) Presence of metal ions causes disassembly of AuNPs 
changing color from blue to red. [20] 
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The schematic of the working of a basic AuNPs based colorimetric sensor has 
been shown in Figure 3 [20]. The presence of analyte can lead to (a) aggregation of 
AuNPs or (b) disassembly of aggregated AuNPs. The aggregation of AuNPs is followed 
by broadening of the SPR band and change in visual color from red to blue due to the 
size dependent optical property. However, the disassembly causes a change from blue 
to red and blue shift in the SPR absorption band.  
 
1.2.2 Enzyme-linked immunosorbent Assay  
The basic principle of ELISA was pioneered in 1971 by two Swiss scientists: Engvall and 
Perlmann [21-23]. They modified Radioimmunoassay (RIA) method by replacing 
radioactive iodine with enzymes. Because of the hazardous effect of using radioactive 
iodine, RIA assays were modified, thus creating modern day ELISA technique. The initial 
research work were focused on determining the level of IgG in rabit serum and quantifying 
human chorionic gonadotropin in urine using horseradish enzyme [21, 23]. After the 
invention of ELISA, a lot of work was done in the field of diagnostic microbiology, 
parasitology and to detect viral proteins such as influenza, parainfluenza, mumps etc in 
the year 1973-1981 [24-29]. 
The working of ELISA is based on interaction of antigen to its specific antibody, 
which makes it possible for the detection of very small amount of antigen such as proteins, 
peptides or antibodies in a fluid sample. ELISA utilizes enzyme labelled 
antigens/antibodies to achieve an amplified output signal in the presence of very small of 
antigen. The common enzymes used are glucose oxidase, alkaline phosphatase, 
horseradish peroxide etc which yields a change in color or a fluorescence signal in the 
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presence of the molecule of interest. Quantitative analysis is done by measuring the 
intensity of fluorescent signal or color change which is further analyzed by a reader. 
Various modifications in the process of ELISA has been done in the recent decade as 
shown in Figure 4. These are as follows:  
(a) Direct ELISA- The direct type of ELISA involves the immobilization of antibody/antigen 
on the surface of the plate. The enzyme tagged antibody/antigen is introduced and incubated for 
a particular amount of time, after which the plate is washed off to remove unbound material from 
the wells. An appropriate substrate is added to the well which produces an output signal through 
development of color.  
(b) Indirect ELISA- The process includes the involvement of an enzyme tagged secondary 
antibody which attaches to the primary antibody-antigen complex and helps in the development 
and quantification of a signal. This type of method was first developed by Lindström and Wager 
in 1971 to measure porcine IgG antibody [30].  
(c) Sandwich assay- The sandwich assay includes capturing an antigen between two 
different types of antibodies- capture and detection antibody. The capture antibody is immobilized 
on the surface of plate which attaches to the antigen and then detection antibody tagged with an 
enzyme is added which gives the output signal in the presence of a substrate. The signal is directly 
proportional to the concentration of the antigen [31]. 
(d) Competitive assay- The surface of the wells is immobilized with antibodies specific to the 
antigen. The sample containing antigen is added in the wells along with another tagged antibody. 
The immobilized antibody competes with the tagged antibody to bind to the antigen present in the 
well. The excess antibody is washed off and substrate is added to produce the signal. The signal 
is inversely proportional to the concentration of the antigen in the serum [22]. 
(e) Nanoparticle based immunoassay- Recently, nanoparticles have been utilized to 
develop novel immunoassays due to their unique physical, chemical and biological properties. 
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These materials have been adapted to improve the degree of sensitivity of a biosensor due to 
their potential for operating without enzymes or replacing enzymes overall [32]. The surface of 
the nanoparticles can be easily modified with target binding molecules and due to their existence 
in different colours, the need of substrate is entirely unnecessary. The application of nanoparticles 
in the detection of heavy metal ions, proteins, peptides, DNA and even cells have shown great 
potential attributing to their enhanced stability and cost effectiveness of the developed sensors.   
 
 
Figure 4: Different types of ELISA techniques [22]. 
 
 
1.2.3 Organic Electrochemical transistors 
The field of organic transistors provide an attractive means for the detection and 
quantification of biomolecules for the applications in medical and health care industry [33-
36]. The miniaturization, easy electrical read out signals, signal amplification as well as 
robustness are the key advantages of these devices which have given them an edge over 
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other approaches. A wide range of sensors such as pressure, humidity, pH, mechanical 
deformation and ion concentrations etc have been successfully developed using the 
organic transistors[37-39].  
 
Figure 5: A flowchart showing different components of a biosensor [34]. 
All these sensors have different functions; however, the basic schematic comprises of the 
following entities (Figure 5): 
(a) Bioreceptors (enzyme, antibodies, aptamers etc) which is specifically designed to bind the 
analyte molecule.  
(b) Electrical interface- where the specific biological event such as binding, redox reaction etc 
takes place. 
(c) Signal amplifier- The transduction and amplification of the biological event into an output 
electrical signal. 
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(d) Signal processor- The computer software which converts the change in electrical signal in 
some form of physical parameter which is read though display. 
(e) Display-an interface between the computer and the human operator which displays the 
detection and quantification parameters in readable form.  
Different operating modes of a transistor include amperometric (change in current), 
conductimetric (change in conductivity of the medium) and potentiometric (change in 
potential) sensors [37, 40-42]. The major class of electrochemical detection techniques 
utilizes field-effect transistor in which the change in current is measured due to the change 
in potential at the gate electrode. Within the family of FETs, an organic electrochemical 
transistor (OECT) consists of two electrodes- source and drain connected by an active 
layer of semiconductive material and a third electrode called gate which controls the 
conductivity of the channel. A typical OECT based biosensor involves the modification of 
metal gate electrode with a biologically active component (bioreceptors such as enzyme, 
antibodies, aptamers etc) which transduces an electrochemical signal in the presence of 
specific analyte [43]. The working of the device depends on the doping/de-doping of the 
semiconducting layer bridging the channel. The transistor is a combination of sensor as 
well as amplifier where a small change in the potential causes significant change in the 
current. This occurs in low operating voltages which is suitable for biological and chemical 
sensing in aqueous environment [44].  
Researchers have been emphasizing on the use of nanotechnology to shrink the 
dimensions of the device which will ensure high signal to noise ratio, small sample usage 
and ultimately a more compact device. Research has also been focused on the advent of 
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new bioreceptors molecules which offers high specificity and affinity towards the molecule 
of interest. Most of the electrochemical sensors depend on the use of some electroactive 
label molecule (Fluorescent, chemiluminescent or radioactive labels) which facilitates the 
transfer of electron in the presence of analyte resulting in a change in the potential. The 
major drawback of using labels is to immobilize the label molecule over the analyte and 
the limited stability of the label in harsh environmental conditions. Therefore, lot of 
research has been done towards exploring label free biosensors to develop more reliable 
biosensors for practical applications [45-47]. An ideal biosensor is stable at a wide range 
of temperature, pH and humidity and does not show variations between different assays. 
It is cheap, portable, compact, user-friendly and provides real-time analysis in a timely 
fashion.   
 
1.3 Introduction to Aptamer   
The word aptamer is taken from Latin word ‘aptus’ which means to fit [48, 49]. Therefore, 
the word aptamer denotes a kind of polymer which fits to its target. Aptamers are short 
synthetic strands of oligonucleotides either, DNA or RNA which specifically binds to a 
target molecule. These are designed and selected through Systematic Evolution of 
Ligands by Exponential Enrichment (SELEX) procedure. First a combinatorial library of 
random oligonucleotide sequences is formed. A target molecule is incubated with the 
random sequences in an appropriate buffer and at particular temperature and pH. Then, 
the free nucleotides are washed away and bound nucleotides are eluted. This process 
consists of repetitive steps alternating between selection and amplification by using PCR 
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(polymerase chain reaction). The strands showing highest affinity towards the target 
molecule with Kd value in the nanomolar to picomolar range are extracted. It can be noted 
that the process of SELEX does not necessarily favor the production of aptamer for a 
single epitope on the given target. Till now, a wide range of aptamers has been designed 
for targets such as nucleic acid  [50], proteins [51, 52] small organic molecule [53], metal 
ions [54], viruses [55], bacteria [56] and antibiotics. Aptamer can bind to the target 
molecule by a lock and key mechanism through conformational change (Figure 6) and 
other forces such as van der Waals interactions, hydrogen bonding and electrostatic 
interactions also play a major role [49]. 
 
 
Figure 6: Schematic diagram showing the conformational change in the presence of a 
target molecule [57] 
 
1.3.1 Aptamer vs Antibodies  
When compared with antibodies, aptamer provide numerous advantages. Some of them 
are as follows: 
A. Synthesis- Antibody are extracted by an in vivo process using animal’s immune 
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response against a particular target whereas aptamers are chemically synthesized by 
SELEX process. 
B. Reproducibility- Chemical synthesis of aptamers reduces batch-to-batch variation in 
aptamer and also reduces cost of production. These can be synthesized with high 
degree of purity, extreme accuracy and reproducibility. 
C. Ease of functionalization- Aptamers ends can be functionalized easily with labels or 
other molecules for easier immobilization or target purification. 
D. Stability- Antibodies are very sensitive to the variation in temperature or pH and can 
easily undergo denaturation. On the other hand, the aptamers are stable at high 
temperatures and can be renatured within few minutes to maintain the structure. 
E. Aptamers have been a good alternative to antibodies. However, a major drawback of 
using aptamer is degradation by nucleases. Therefore, the entire experiment has to 
be done in a DNAase - RNAase free environment. 
1.4  Scope of the thesis 
The scope of the present thesis is to develop novel diagnostic tools for application in the 
point of care testing devices. The present thesis is organized in the following chapters. 
Chapter 2 demonstrates the development of a colorimetric sensor based on the 
aggregation of gold nanoparticles in the presence of specific analyte molecule. A detailed 
study to investigate the role of physical morphology of AuNPs, aptamer concentration as 
well as the effect of salt has been performed to better understand and control the 
sensitivity of the approach. 
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Our goal in chapter 3 is to detect epinephrine in picomolar range using an 
electrochemical platform. The novelty in this work is the use of aptamer modified gate 
electrode which regulates the output current in the presence of epinephrine. The device 
exhibited high sensitivity (90 pM detection range) and specificity for epinephrine (no 
response towards common interfering agents) due to the use of aptamers.  
In Chapter 4, an attempt has been made to develop a multiplex analyte detection 
system using a PDMS based microfluidic channel which gives an easy colorimetric 
readout signal. Zika and Chikungunya envelope proteins has been detected at picomolar 
range with naked eye detection using aptamer functionalized micro-pillars. The use of 
microfluidic channel offered advantages such as smaller sample volumes, lower cost, 
easy disposal as well as high throughput. Finally, chapter 5 discusses the conclusions 
and future work for the advancement of the thesis. 
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CHAPTER 2: COLORIMETRIC DETECTION OF EPINEPHRINE USING 
AN OPTIMIZED PAPER-BASED APTASENSOR  
 
2.1 Introduction 
The global market for medical diagnostic industry is worth 25 billion dollars in the United 
States and will continue to grow each year [58]. Presently, available methods for 
biodetection, such as immunoassays, [59, 60] chemiluminescence [61-63] and 
fluorescent based assays, [64, 65] are expensive, time consuming and require skilled 
labor with high-end instruments. Therefore, development of novel, passive colorimetric 
sensor and diagnostic technologies for detection and surveillance has garnered utmost 
importance. Paper-based sensors employing gold nanoparticles (AuNPs) as colorimetric 
probes have gained attention due to their simplicity, robustness and scalability [66-68]. 
These sensors are easy to fabricate and are capable of handling very small volumes of 
liquid (microliter) which greatly reduces reagent and sample consumption.  
Gold nanoparticles (AuNPs) exhibit unique optical properties due to their bright red 
color in solution which is highly dependent on the interparticle distance.[7, 69] Despite 
being the noble metal in the bulk state, AuNPs act as catalysts in nanoscale and therefore 
show promising applications in electronics, [70] photonics, [71] chemical sensing and 
imaging [72-74]. The optical properties of AuNPs can be tuned throughout visible to near 
The work presented in this chapter has been published in  
RSC Advances, 2017, 7, 49133-49143; DOI:10.1039/C7RA10272K  
Reproduced by permission of The Royal Society of Chemistry. 
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infra-red spectra by varying AuNPs size, shape, local environment and aggregation state 
[14, 75-79]. When AuNPs of ~10-20 nm size are uniformly dispersed in solution, they 
exhibit a strong plasmon peak at ~520 nm due to the collective oscillations of the free 
electrons in the conduction band. Any change in physical parameters will cause a shift in 
the electron density, resulting in changes in oscillation frequency, absorption and 
scattering spectra and hence, the visible color of the AuNPs solution from red to blue. 
This approach can be used to design simple biosensing devices to detect various kinds 
of molecules. 
Aptamer-functionalized gold nanoparticles (AuNPs-apt) have also attracted 
attention for use in detecting small proteins, [58, 80-83] oligonucleotides [19, 75, 84, 85] 
and metal ions [86-88] due to their low cost, simplicity and practicality [89-92]. Aptamers 
are short, synthetic oligonucleotide strands of either DNA or RNA which are synthesized 
by a procedure called Systematic Evolution of Ligands by Exponential Enrichment 
(SELEX) and can be functionalized onto the surface of a nanoparticle [53], [93]. These 
sensory molecules bind to target molecule by a lock and key mechanism driven by a 
conformational change as well as van der Waals forces, hydrogen bonding and 
electrostatic interactions [49]. This binding cause energy/charge transfer between the 
AuNPs-apt and the target, leading to aggregation in the solution. The target-mediated 
aggregation of AuNPs-apt results in the color change of the colloidal gold solution from 
red to blue [94, 95]. This attribute of AuNPs of transferring any biorecognition event into 
a color change has motivated scientists to use AuNPs as a biosensing tool for the 
detection of numerous biomolecules including oligonucleotides, small proteins, 
biomarkers and pathogens.  
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The catecholamine epinephrine (4-[(1R)-1-hydroxy-2-
(methylamino)ethyl]benzene-1,2-diol) is  a neurotransmitter and neuroendocrine 
hormone which acts upon α-adrenergic and β-adrenergic receptors in several organs, 
giving it a vast array of physiological functions [96]. Clinical uses include the treatment of 
anaphylactic shock, cardiac attack and asthma attacks [96]. Abnormalities in epinephrine 
levels may result in myocardial infarction, arrhythmias, pulmonary edema, blood pressure 
increase and Takotsubo cardiomyopathy [97-99]. The level of epinephrine present in the 
plasma is approximately 13.6 x 10-11 M [100]. Detection has previously been performed 
by electrochemical methods, [101-103] liquid chromatography, [104, 105] 
spectrophotometry, [106] electrophoresis, [107] flow injection analysis [108, 109] and 
fluorometry [48, 110]. The estimated detection limit for epinephrine obtained from all these 
experiments was found in the range of nanomolar to micromolar (10-8 to 10-9 M) [100]. 
Though these methods have high detection limits, they are time consuming and require 
skilled labour and expensive instrumentation. As an alternative, gold aptasensors not only 
provide a simple and novel testing tool but also demonstrates high sensitivity and 
selectivity towards epinephrine.  
Despite having all the aforementioned advantages of using AuNPs-apt based 
colorimetric sensors, the biggest challenge which restricts the use of this sensor in real 
world application is the low sensitivity compared to other sensing technologies. The 
detection limit depends on the morphology of the AuNPs, the binding affinity of the 
aptamer, the ratio of the aptamer to the AuNPs and the affinity of the aptamer with respect 
to analyte. The shape, size and the dielectric medium surrounding the particles can be 
tuned such that even small amounts of analyte can trigger maximum aggregation/color 
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change. Along with nanospheres, various shapes such as nanorod and nanostars have 
been utilized for the development of colorimetric sensors [111-113]. However, there have 
been no systematic studies done which compare the effects of different sizes and shapes 
of AuNPs and aptamer-AuNPs interaction on the detection limit of a sensor. Therefore, 
the present work explored the effect of different parameters that govern the detection 
process such as the number of aptamers on the surface of AuNPs, aptamer binding, salt 
concentration and physical morphology of AuNPs. The aim is to optimize all these 
parameters such that a maximum shift in the spectra and an intense change in color can 
be obtained. These optimized parameters have been used to develop a sensitive and 
portable paper based sensor for epinephrine, which can be used as a point of care 
diagnostic tool. 
 
2.2 Experimental Section 
2.2.1 Materials  
Both thiol-modified and unmodified aptamers were used in the present study. The 32-mer 
aptamers specific for epinephrine were designed and synthesized by BasePairBio 
Company (Pearland, TX). Chloroauric acid, trisodium citrate, L-ascorbic acid, tris (2-
carboxyethyl) phosphine (TCEP), tris hydrochloride (Tris HCl), 
ethylenediaminetetraacetic acid (EDTA), phosphine buffered saline tablets, sodium 
chloride (NaCl), magnesium chloride (MgCl2) and epinephrine hydrochloride were 
purchased from Sigma-Aldrich (St. Louis, MZ). Gold Nanospheres (15 nm, 30 nm, 50 nm) 
with concentration of 1 mg/ml and Gold NanoRods (660 nm resonant, 50 OD) stabilized 
by negatively charged citrate ions were obtained from Nanocomposix (San Diego, CA).  
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Experiments were performed in a DNAse - RNAse free environment using nuclease free 
water, tips and vials purchased from Thermofisher (Waltham, MA). Whatmann® filter 
paper #1 was obtained from Sigma Aldrich (St. Louis, MZ). 
 
2.2.2 Instrumentation 
Surface charge and hydrodynamic size measurements were performed using Dynamic 
Light Scattering (DLS) by Zetasizer, Malvern Instrument equipped with 633 nm He-Ne 
laser and a backscatter detector at an angle of 173 degrees. Folded capillary tubes were 
used for measuring Zeta potential at a controlled temperature of 25°C and a fixed voltage 
of 150 V. The Z-average size was calculated using the “General purpose” analysis model 
as provided by the Zetasizer software. For each sample, minimum of 3 measurements 
containing 11 runs of duration 10 seconds was performed. The results for the three 
readings were averaged and standard deviation was calculated to define the error bars 
on the DLS graphs. UV-Vis spectroscopy was performed using FLUOstar Omega plate 
reader to determine the absorbance spectrum in the range of 400-800 nm. UV transparent 
96-well plates were used for the entire study. AuNPs based on their physical 
morphologies exhibit different absorbance peaks in the UV-spectrum. The size and 
morphology studies were also done using Philip (FEI Tecnai F30) high resolution 
transmission electron microscope (HRTEM) operating at 300 keV. The samples for TEM 
were prepared by dip-coating the carbon coated TEM grid in a diluted solution of the 
particles and drying it at room temperature. The steps were repeated multiple times to 
ensure enough AuNPs are present on the grid. The samples were stored under high 
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vacuum overnight to remove any moisture and protect the sample from oxidation. The 
average size of the particles was calculated by using Gatan Digital Micrograph software. 
 
2.2.3 AuNPs Synthesis 
AuNPs were synthesized using the standard citrate reduction procedure as reported in 
the literature previously [114]. Briefly, 100 mL of 1 mM HAuCl4 was heated to boil under 
constant stirring. Next, trisodium citrate solution (2 mL, 194 mM) was added rapidly in the 
stirring solution resulting in a change in solution color from pale yellow to red. The solution 
was boiled for another 20 min and then allowed to cool at room temperature. The solution 
was then filtered using 0.22 µm membrane filter to ensure the monodispersivity of the 
AuNPs and stored at 4°C for long term stability. The concentration was calculated as 14.4 
nM with the help of Beer’s law by using the extinction coefficient of 2.01 x 108 M-1cm-1 
[115]. The entire scheme is shown in Figure 7. 
 
2.2.4 Preparation of AuNPs conjugated with aptamers 
The aptamers were received in a dried pelleted form and were resuspended in TE buffer 
(10 mM Tris HCl, 0.1 mM EDTA, pH 7.5) to achieve a concentration of 100 µM. The 
solution was aliquoted into smaller volumes to avoid multiple freeze and thaw cycles. 
Before immobilization of the aptamers over the AuNPs surface, the aptamers were diluted 
to the required concentration using folding buffer (1 mM MgCl2 and 0.01 M PBS, pH 7.5). 
The aptamers were brought into a folded state by incubating at 95°C for 5 min and another 
15 min at room temperature. The thiolated aptamers were then reduced by using TCEP 
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in 1:1 v/v dilution. The addition of TECP ensures the breakage of any disulphide bonds (-
S-S-) such that free –SH group is available to bind to the gold surface. The reaction was 
incubated for 20 min at room temperature. The unmodified aptamers did not require any 
reduction steps. AuNPs-aptamer complexes were prepared by mixing the AuNPs and 
folded aptamers in 1:1 v/v ratio and kept at room temperature for another hour. Excess 
aptamers were washed away by centrifugation at 14,000 rcf for 11 min and resuspending 
the conjugates in folding buffer. 
 
 
Figure 7: Schematic of AuNPs synthesis using seedless approach 
 
2.2.5 Preparation of hydrophobic Paper substrate 
Paper based substrates made up of cellulose, such as Whatman® filter paper are 
portable, easy to store, readily available and provide high surface area for colorimetric 
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bioassays. The surface and pore size of the Whatman® filter paper can be easily 
functionalized and controlled by various chemical treatments as per requirement [116-
118]. In the present study, Whatman® filter paper was cut into strips and functionalized 
with wax by directly rubbing the solid wax over the paper. The paper was incubated for 
about an hour at 60°C such that the wax spread evenly on the paper surface and seeped 
through the pores of the paper. The wax provides hydrophobic nature to the paper which 
does not allow AuNPs to wet the surface or spread on to the surface of paper [68]. 
 
2.2.6 Colorimetric assays 
25 µl of epinephrine at different concentrations was added to 50 µl of AuNPs-apt solution 
for each colorimetric assay in the 96 well-plate. The amounts and concentrations of 
epinephrine used in the study were 2 µg (360 µM), 1 µg (180 µM), 500 ng (90 µM), 350 
ng (63 µM), 200 ng (36 µM), 125 ng (22 µM), 50 ng (9 µM) and so on. The AuNPs-apt 
and epinephrine solution was incubated for 10 min at room temperature before performing 
the UV-visible spectroscopy. For the different size and shape study, the concentrations 
of the different AuNPs were kept constant at 0.2 mg/ml for an accurate comparison of the 
detection limit. Each assay was performed at least in triplicate and the data is represented 
as mean ± standard errors. 
 
2.3 Results and Discussions 
2.3.1 AuNPs Characterization 
Figure 8 shows detailed characterization of the as-synthesized (13 nm spherical 
particles) and purchased AuNPs. AuNPs (13 nm) were synthesized using the standard 
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procedure of citrate reduction of HAuCl4 as shown in Figure 7. The hydrodynamic radii 
of the gold colloids are 18.15 nm, 20.10 nm, 36.48 nm, 52.47 nm and 55.91 nm as 
measured with DLS instrument and it can be seen that all the particles are in a very narrow 
range with minimum/no agglomeration (Figure 8A). Zeta potential results (Figure 8B) 
indicate that the citrate coated particles are negatively charged with surface charge as -
21.9 mV, -28.33 mV, -37.8 mV, -52.2 mV -52.5 mV and -43.9 mV and this charge 
increases with respect to the size of the particles. The negative charge of AuNPs induces 
stability in the solution and prevents unwanted agglomeration. AuNPs of diameter 13 nm, 
15 nm, 30 nm and 50 nm stabilized in water exhibited distinctive peaks (surface plasmon 
band, SPR) at around 518 nm, 520 nm, 524 nm and 528 nm respectively (Figure 8C). 
The SPR of the AuNPs is modified when the shape deviates from spherical geometry 
[119]. In the case of rods, the electrons are found to oscillate in the transverse as well as 
longitudinal direction. The transverse mode showed a resonance peak at approximately 
520 nm whereas the longitudinal direction peak was observed at 670 nm (Figure 8D). 
Nanourchin shaped particles exhibited a broad, shifted peak at ~562 nm due to the 
presence of spikes which results in complex localized surface plasmon resonance 
(LSPR). Different absorption peaks of these particles cause changes in their visible color 
(Figure 8D). 
 High resolution transmission electron microscopy (HRTEM) images of the as 
prepared and purchased nanoparticles are shown in Figure 9 (A-F). HRTEM images 
revealed that particles are uniformly dispersed and have spherical, spiky and rod-like 
morphologies. The average sizes are in order of 12.74 nm, 14.66 nm, 27.77 nm, 48.71 
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nm, 53.76 nm and 45.34 nm (Table 1). The next section discusses the effect of aptamer 
concentration as well as the binding mechanism on the aggregation of the AuNPs. 
 
 
Table 1: Summary of the properties of gold nanoparticles as characterized through 
various techniques. 
 
Gold 
Nanoparticles 
Zeta potential 
(mV) 
SPR band 
(nm) 
Hydrodynamic 
Size (nm) 
TEM average 
size (nm) 
 
Sphere-13 nm -21.9 518 18.15 ± 2.1 12.74 ± 0.5 
Sphere-15 nm -28.33 520 20.10 ± 0.6 14.66 ± 0.3 
Sphere-30 nm -37.8 524 36.48 ± 0.3 27.77 ± 1.2 
Sphere-50 nm -52.2 528 52.47 ± 0.4 48.71 ± 2.5 
Nanourchin -52.5 562 55.91 ± 0.4 53.76 ± 6.3 
Nano Rods -43.9 520, 620 - 45.34 ± 0.4 
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Figure 8: Thorough characterization of different kind of AuNPs. (A) Dynamic Light 
scattering measurements showing the diameter of the spherical particles as well as 
nanourchins. The mean sizes observed are 18.15 nm, 20.10 nm, 36.48 nm, 52.47 nm 
and 55.91 nm respectively. (B) Surface zeta potential of the given samples shows the 
presence of negative charge with a small error bar. (C) Normalized UV-visible spectra of 
the spherical particles with SPR bands at 518 nm, 520 nm, 524 nm and 528 nm. (D) 
UV-Visible spectra of different shapes of AuNPs. The maxima was observed at 518 nm, 
562 nm for spheres and urchins where as for rods, these were 520 nm and 670 nm. The 
inset shows the visible color of different shapes- Spheres (red), Rods (Green) and 
Nanourchins (Purple). 
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Figure 9: High Resolution Transmission Electron Microscope analysis for different sizes 
and shapes of gold nanoparticles. (A-F) images show the TEM for 13 nm, 15 nm, 30 
nm, 50 nm, Nanourchins and Nano Rods respectively. The length is calculated using 
Digital Micrograph software provided by Gatan.  
 
 
 
27 
 
 
Figure 10: Visible color change in the solution of AuNPs conjugated with different 
concentration of thiolated aptamers (0.02 nM to 2 µM) in presence of Epinephrine. The 
change in color represents aggregation in the solution. The AuNPs started aggregating 
when the aptamer concentration was 20 nM or less and minimum concentration of 
epinephrine was 200 ng. 
 
2.3.2 Effect of Aptamer Concentration 
13 nm AuNPs were conjugated with different concentrations of the epinephrine-binding 
aptamer (2 µM, 200 nM, 20 nM, 2 nM, 0.2 nM and 0.02 nM) and tested against a range 
of concentrations of epinephrine (2 µg (360 µM), (1 µg (180 µM), 500 ng (90 µM), 350 ng 
(63 µM), 200 ng (36 µM) and 50 ng (9 µM)). Figure 10 shows the visual color change at 
different aptamer concentration in the presence of epinephrine and the corresponding 
UV-Visible spectra of these samples is represented in Figure 11. The destabilization of 
the charge causes aggregation in the solution which can be seen from the TEM analysis 
as shown in Figure 12. 
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 The change in color was observed in solutions starting from 200 ng of epinephrine 
and aptamer concentration ranging from 0.02 nM-20 nM. It was observed that the SPR 
of AuNPs at 520 nm broadens and shifts to a longer wavelength as a function of the 
epinephrine concentration. The degree of aggregation is represented in terms of A640/A518 
where A640 and A518 indicate the absorbance intensity at 640 nm and 518 nm, respectively. 
Figure 13 demonstrates a comparative analysis of different samples. It can be seen that 
the increase in aptamer concentration (20 nM, 200 nM and 2 µM) decreases the detection 
limit of the AuNPs–apt system. There was no aggregation observed in the 2 µM aptamer 
solution at any epinephrine concentration.  
This result of decreased detection with increased aptamer concentration is due to 
the fact that as epinephrine is introduced into the solution, the free unbound aptamer 
binds to it [120]. Since the epinephrine molecule is very small in size (Molecular Weight: 
219.67 Da), the aptamer wraps around the molecule, making it very difficult for the 
molecule to interact with the other aptamers present on the gold surface, thus inhibiting 
aggregation of the AuNPs. Also, the conjugated aptamers add to the overall negative 
charge of the AuNPs, enhancing the stability of the AuNPs by increasing the electrostatic 
repulsion between the particles [121, 122]. It can be observed that the optimized range 
of aptamer for maximum detection of the analyte is below 20 nM aptamer concentration 
which can detect epinephrine levels as low as 200 ng. At lower concentration of aptamers, 
a linear increase in the ratio was observed at 50 ng , 200 ng and 350 ng of epinephrine 
which becomes constant at higher concentrations of epinephrine. 2 nM aptamer 
concentration gave the maximum A640/A518 ratio which suggest that it is the optimum 
aptamer concentration at which maximum aggregation was seen in the solution at 200 ng 
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of epinephrine. Higher concentration of aptamer induces excess stability in the solution 
as discussed previously. The aptamer concentration lower than 2 nM i.e. 0.2 nM and 0.02 
nM is insufficiently low in number and in the presence of low concentration of the 
epinephrine molecule, not enough aptamers are present to induce aggregation in the 
AuNPs solution. Therefore, AuNPs are conjugated with 2 nM aptamer concentration for 
further experiments. The aptamers can be physically adsorbed [122] on the surface of 
AuNPs or can bind to the surface of AuNPs via covalent bonding [123, 124]. The following 
experiment compares the two different types of the aptamers and studies their effect on 
the aggregation. 
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Figure 11: UV-Vis spectra of AuNPs conjugated with different concentration of thiolated 
aptamers (0.02 nM to 2 µM) in the presence of Epinephrine (50 ng- 2µg). The 
experiment demonstrates the effect of aptamer and analyte concentration on the 
aggregation of AuNPs. (A) 2 µM aptamer concentration causes the gold nanoparticles 
to be very stable and  excess of aptamer in the solution binds to the Epinephrine 
inhinbiting aggregation in the solution. Therefore, no red shift was observed. (B) A slight 
shift in the peak at 640 nm was seen in the presence of 2 µg and 1 µg of Epinephrine 
when the aptamer is 200 nM. (C, D, E) Similar response was seen for 20 nM, 2nM and 
0.2 nM aptamer concentration with an intense shift in the peak at 640 nm. Minimum 
amount of Epinephrine detected was 200 ng. At 50 ng, the Epinpehirne concentration is 
too low to induce any aggregation in the solution. 
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Figure 12: High Resolution Transmission Electron microscope image for (A) uniformly 
dispersed AuNPs and (B) aggregated AuNPs in the presence of Epinephrine. Inset 
showing higher magnification with a scale bar of 20 nm. 
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Figure 13: Comparative analysis of the A640/A518 ratio as derived from UV-Visible 
spectroscopy analysis of samples containing different amount of aptamers (2 µM, 200 
nM, 20 nM, 2 nM, 0.2 nM and 0.02 nM) as a function of epinephrine concentration 
represented in logarithmic scale (2 µg (360 µM), (1 µg (180 µM), 500 ng (90 µM), 350 
ng (63 µM), 200 ng (36 µM) and 50 ng (9 µM)). The increase in the ratio is in 
correspondence with the color change in the solution. Solution with 2 nM concentration 
(green curve) shows the most significant increase in the ratio at 200 ng of Epinephrine 
which indicates maximum aggregation in the solution.  
 
 
 
2.3.3 Effect of thiolated and non-thiolated aptamer conjugation 
Aptamers can bind to the surface via covalent bond (Au-thiol interactions) [123, 124]  or 
it can be adsorbed on the surface via electrostatic interactions [122]. Figure 14 
represents the comparison between the thiolated and non-thiolated epinephrine aptamer 
and its effect on the sensitivity of the aptasensor. As it was observed earlier that 200 ng 
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of epinephrine induced intense color change in the solution and red-shift in the UV 
spectrum, the AuNPs-aptamers were now tested against 125 ng of epinephrine. It can be 
seen from Figure 15 (A, B, C), 125 ng induced slight color change in the solutions in the 
presence of aptamer ranging from 20 nM-0.02 nM. However, the UV-Visible data (Figure 
15) shows the highest peak at 640 nm which belonged to 2 nM aptamer. The maximum 
A640/A518 ratio was achieved for 2 nM of the thiolated aptamer as shown in Figure 14. The 
thiolated and non-thiolated produced similar results in terms of color change but UV-
visible data showed that the thiolated aptamers are more efficient in detecting the analyte.  
The variation in detection of analyte by thiolated versus non-thiolated aptamers is 
due to differences in the underlying mechanisms of these two approaches. Thiolated 
aptamers bind strongly to the surface of the gold and when the analyte approaches, 
AuNPs are pulled together strongly to form aggregates [125]. The repulsion between the 
citrate capped AuNPs is dominated by the affinity of aptamers towards the analyte. The 
presence of epinephrine bound with the aptamers causes destabilization in the charge of 
AuNPs which results in aggregation/color change. On the other hand, the unmodified 
aptamers are loosely attached to the AuNPs surface. In the presence of epinephrine, the 
aptamers attain a tertiary folded conformation and detach themselves from the surface, 
leaving the AuNPs destabilized [122, 126]. The extent of destabilization depends on the 
concentration of analyte and the number of aptamers detached from the surface. The 
lesser shift in the peak at ~640 nm in the presence of unmodified aptamers is due to 
aptamers remaining attached to the surface of AuNPs and screening them from 
aggregation. However, the difference is very minor, and therefore, it can be concluded 
that both thiolated and non-thiolated aptamers behave almost the same for low 
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epinephrine concentrations. Moving forward, thiolated aptamers were used at 2 nM 
concentration for testing the effect of AuNPs physical morphology on the detection of 
epinephrine. 
 
 
 
 
 
Figure 14: Comparative analysis of thiolated and non-thiolated aptamer on the surface 
of AuNPs in the presence of 125 ng of Epinephrine. The absorbance ratio (A640/A518) as 
calculated by UV-visible spectra represents maximum aggregation in 2nM thiolated 
aptamer solution. The columns represent the mean value and the error bars indicate the 
standard deviation in the experiments. 
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Figure 15: Comparative analysis of thiolated and non-thiolated aptamer at the surface of 
AuNPs on the sensitivity of the aptasensor. (A) UV-visible spectra for the AuNPs 
conjugated with thiolated aptamer. The peak for 2 nM aptamer has shown maximum 
intensity at 640 nm as compared to other concentrations of the aptamer. (B) UV-Visible 
spectra for the non thiolated aptamers. (C) Visible color as observed immediately after 
addition of Epinephrine did not show much color change as noticeable by the naked 
eyes. 
 
 
 
2.3.4 Effect of Different Sizes 
 So far, the effect of aptamer concentration and the thiolated and non-thiolated binding of 
the aptamers has been discussed. 2 nM thiolated aptamer showed maximum sensitivity 
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and visible color change towards 125 ng of epinephrine with a maximum peak intensity 
at 640 nm. Different sizes of spherical gold nanoparticles (13 nm, 15 nm, 30 nm and 50 
nm) have been used to test the limit of detection of the aptasensor. Figure 16 (A, B) 
shows the response of different sizes of AuNPs in the presence of 125 ng and 200 ng of 
epinephrine. The UV-Visible spectrum shows that the 13 nm AuNPs (black curve) 
exhibited a greater red shift in the presence of 125 ng and 200 ng epinephrine compared 
to other particles. No shift was seen for 30 nm and 50 nm AuNPs. The derived absorbance 
ratio (A640/A518) from the UV-Visible spectra (Figure 16 C) confirms that the maximum 
aggregation was observed for 13 nm particles, followed by 15 nm particles with little to no 
shift for 30 nm and 50 nm AuNPs. 13 nm AuNPs also exhibited the maximum color 
change for all tested concentration of epinephrine (Figure 17).  
The strongly bound citrate group induces negative charge on the surface of the 
AuNPs which leads to repulsion between the particles [127]. Since the 50 nm AuNPs 
have the maximum negative surface charge (Table 1), very little aggregation was 
observed in the solution. Because larger sized particles are bulkier than smaller ones, 
higher concentrations of analyte are required for the aptamers to agglomerate the 
particles. The combined effect of the negative zeta potential as well as the interaction of 
aptamer and analyte is responsible for no color change in larger particles.  
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Figure 16: Size dependent study for the detection of Epinephrine. (A, B) UV-Visible 
spectra showing aggregation in the solution of different sizes (13 nm, 15 nm, 30 nm and 
50 nm) of AuNPs at 125 ng and 200 ng of epinephrine. (C) Plot showing trend for the 
derived absorbance ratio (A640/A518) for different sized particles. 13 nm particles showed 
maximum aggregation in presence of 200 ng and 125 ng of Epinephrine. 
 
 
Figure 17: Visible color change in the solution of different sized AuNPs-aptamer (13 nm, 
15 nm, 30 nm, 50 nm) in the presence of different concentration of Epinephrine (50 ng, 
125 ng, 200 ng). (A) without salt (B) In the presence of salt (170 mM, 10 µl). Maximum 
color change can be observed for 200 ng for 13 nm AuNPs particles. 
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2.3.5 Effect of different shapes: Rods, spheres and urchins 
Anisotropic nanomaterials with highly complex structures have generated wide spread 
interest owing to their enhanced physical and optical properties. In the present section, a 
comparative analysis of different shapes of AuNPs used for the detection of epinephrine 
has been carried out and the basic characterization is shown in Figure 8 and 9. The 
aptamer conjugation process and the concentration of all AuNPs was kept constant as 
used for the spherical particles. Figure 18 (A-D) summarizes the result of the assay. The 
UV-visible spectra showed an intense red shift in the peak of spherical particles  (Figure 
18 A). The maximum shift was seen by addition of 500 ng of epinephrine followed by 250 
ng and 125 ng. The color change is also in line with the UV shift with maximum change 
caused by adding 500 ng of epinephrine. In the case of rods, there was no shift in the 
peaks or change in color. The intensity at peak 670 nm showed a constant decrease with 
respect to the epinephrine concentration and a very slight shift towards a lower 
wavelength. In rods, the red or blue shift is a result of change in the aspect ratio. The 
slight blue shift is due to the decrease in the aspect ratio which indicates that some of the 
rods have aggregated due to epinephrine. However, there was no change in color 
observed for the rods. Nanourchins on the other hand showed no change in the UV-visible 
spectra or visible color following the addition of epinephrine. As observed earlier, bigger 
size and greater negative charge leads to stability of the particles and lowers the detection 
limit. The rods and urchins both have sizes in the range of 50 nm and the zeta potential 
is also higher as compared to 13 nm spherical particles (Table 1). Also, the aggregation 
behavior of the rods and spheres are different from each other. Nanorods are more stable 
than the spherical particles as nanorods are known to possess steric hindrance which 
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causes low packing density and smaller aggregates [128-130]. The spheres and urchins 
both have higher curvature, thus higher packing density; however, the spiky structure 
disrupts aggregation of urchins. Therefore, spherical particles with size between 13-15 
nm are the most suitable particles for the colorimetric sensor.  
 
Figure 18: Detection of Epinephrine using different shapes of AuNPs. Fig. A, B and C 
represents the change in UV visible spectra in presence of 13 nm spherical AuNPs, 
Gold nanorods and 50 nm Nano urchin. Spherical particles show clear red shift at 500, 
250 and 125 ng of Epinephrine whereas in case rods and nanourchin, very slight 
change in the intensity of the peaks can be seen. The color change as shown in Figure 
D is prominent for spherical particles whereas no color change was observed for Rods 
and Urchin. 
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2.3.6 Selectivity of the sensor 
The specificity of the present colorimetric sensor was tested by using common interfering 
agents such as 3, 4-dihydroxyphenylacetic acid (DOPAC), ascorbic acid, tryptophan, 
homovanillic acid (HVA), tyrosine, glycine and bovine serum albumin (BSA). 900 µM of 
control samples were tested against 90 µM (500 ng) epinephrine to test the specificity of 
AuNPs-apt. Maximum shift in UV-spectroscopy is obtained by the addition of epinephrine, 
with very little shift being induced by dopamine and no shift by other controls (Figure 19). 
These results demonstrate the high specificity of this colorimetric biosensor against 
epinephrine. 
 
2.3.7 Aggregation Study-Time based study  
The aggregation kinetics was studied by examining the rate of aggregation with respect 
to the analyte concentration. Two different concentrations of epinephrine (200 ng and 125 
ng) were used to induce aggregation in the solution and the size of the aggregates was 
calculated using DLS. 200 ng of epinephrine induced immediate aggregation in the 
solution. The change in size in the presence of 200 ng and 125 ng of epinephrine at 
different time intervals (0 min, 10 min, 30 min, 1 hour, 2 hours and 3 hours) is shown in 
Figure 20. It can be seen that in presence of 200 ng of epinephrine, the solution started 
showing an increase in size immediately with the initial size of 21.38 nm as compared to 
the 18.16 nm of 125 ng epinephrine. A gradual increase in size can be observed for 200 
ng of epinephrine; however, no change in size of AuNPs-apt was observed in the 
presence of 125 ng for almost half an hour (Figure 20). After 1 hour, the size increased 
from 18.16 nm to 31.21 nm. For both samples, the size remained constant after 2 hours.  
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This is in compliance with the established studies in the literature which suggest that this 
is due to the completion of charge transfer and stabilization of the aggregates [127]. When 
the interparticle distance is greater than the average radius of the particles, the particles 
are uniformly dispersed in the solution and emits red color whereas when the interparticle 
distance is less than the average radius, the solution starts changing to blue color. After 
24 hours, the aggregated particles precipitated in the plate and showed no further 
increase in size. 
 
 
Figure 19: Specificity test: UV-Visible spectra of AuNPs conjugated with 2nM aptamer at 
900 µM concentration of interfering agents such as BSA, Ascorbic acid, Tryptophan, 
HVA, Tyrosine, Glycine, DOPAC and Dopamine. Epinephrine (500 ng) caused 
maximum shift in the UV-Visible spectra. Control represents the sample without any 
analyte in the solution. 
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Figure 20: Comparative analysis of the change in size of AuNPs in the presence of 200 
ng (black) and 125 ng (gray) of Epinephrine. 
 
 
2.3.8 Effect of salt  
As discussed previously, the surface of the synthesized AuNPs is derivatized with citrate 
ligands which provide them stability against aggregation. Increases in salt concentration 
increase the ionic strength of a solution which results in screening of this repulsion force 
and induction of aggregation/flocculation of AuNPs. When the AuNPs are conjugated with 
aptamers, the aptamers protect the surface of the AuNPs against salt induced 
aggregation. However, the presence of epinephrine bound to the aptamer decreases the 
overall negative charge of the AuNPs and causes destabilization of the apt-AuNPs. 
Addition of salt further amplifies the charge destabilization and causes aggregation in 
solution. 
The present AuNPs-aptamer system was tested against a range of NaCl 
concentration and it was observed that 170 mM NaCl induced no shift in the UV spectra 
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and was therefore chosen for further experiments. Figure 21A shows the UV-Visible 
spectra of the AuNPs-aptamer in the presence of different concentration of epinephrine 
after the addition of 170 mM NaCl. There is a clear red shift in the spectra with the 
increase in the concentration of epinephrine. The derived absorbance ratio (A640/A518) 
increases proportionally from 0.22 to 1.15 with increase in the epinephrine concentration 
which corresponds to aggregation in the solution (Figure 21B). The lowest amount of 
epinephrine that induced red shift in the spectra was 0.005 ng (0.9 nM) as shown in 
Figure 21. In the absence of epinephrine, the aptamers conjugated AuNPs show high 
stability against NaCl and no red shift was observed in the UV-Visible spectra. The 
present approach with the optimized parameters was then tested on a hydrophobic paper 
substrate to formulate an easy-to-use device. 
 
 
 
Figure 21: Effect of addition of salt on the detection limit of the sensor. (A) UV-Visible 
spectroscopy showing spectral shift in the presence of difference concentration of 
epinephrine ranging from 0.5 pg to 500 ng (0.09 nM to 90 µM) and salt (170 mM). 
Addition of salt causes red shift in the spectra in the presence of epinephrine whereas 
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no shift was seen for the blank sample (no analyte). (B) The derived absorbance ratio 
(A640/A518) increases proportionally with the increase in epinephrine concentration. 
Lowest concentration of epinephrine that induced red shift in the UV-Visible spectra is 
0.9 nM. 
 
2.4 Paper based sensor  
So far, it has been discussed that 13 nm spherical particles when conjugated with 2 nM 
thiolated aptamers in the presence of salt showed high detection limit for epinephrine (0.9 
nM). The increase in concentration of epinephrine leads to increase in aggregation and 
thus increases the intensity of color change as seen from the shift in UV-Visible spectra. 
The concentration of AuNPs was varied to study the effect on the detection of 
Epinephrine. The AuNPs conjugated with aptamer were concentrated to 2X, 3X and 4X 
times by centrifuging at 11500 rcf for 11 min resulting in a concentration of 14 nM, 21 nM 
and 28 nM. The results demonstrated that 4X concentration showed the maximum 
sensitivity towards epinephrine. As explained earlier, the aggregation depends on the 
interparticle distance as well as the radius of the particles. In 4X solution, the number of 
AuNPs is four times the original solution in a same volume of the solution. The distance 
between each particle decreases, therefore, the probability of aggregation as well as the 
intensity of color change also increases with increasing concentration. The AuNPs-
aptamer based biosensor with all the optimized parameters were then used for the 
fabrication of a paper based sensor.  
The color change on the paper was calculated quantitatively using the red-green-
blue values of each AuNPs spot determined by image processing software (Color helper, 
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2013) [131]. The blue/red ratio directly correlates with the degree of aggregation in the 
solution and hence the concentration of epinephrine. 10 µl of AuNPs-aptamer was added 
on the surface of the paper and different concentrations of epinephrine (9 µM, 4.5 µM, 
1.8 µM, 9 µM, 900 nM, 90 nM, 9 nM, 900 fM, 90 fM) were added onto the drop of AuNPs 
solution. To enhance the aggregation in the solution, 2 µl of 170 mM NaCl was also added 
in all the samples which resulted in immediate color change (Figure 22). The addition of 
as low as 9 nM epinephrine began inducing color change in the solution and resulted in 
a significant increase in the B/R ratio. The B/R value for AuNPs without aggregation in 
the solution was found to be around 0.58 and addition of epinephrine increases this value 
to more than 1 which indicates aggregation of AuNPs-apt in solution. 
The developed paper based sensor can be used in conditions where plasma 
catecholamines reach supraphysiological levels. In patients with stress induced 
cardiomyopathy (Takotsubo cardiomyopathy) and Killip Class III myocardial infarction, 
epinephrine levels average 6.9 x 10-9 M and 2.1 x 10-9 M after 1 or 2 days, respectively 
[132]. Normal physiological serum epinephrine concentration is approximately 0.13 x 10-
9 M, which is below the detection limit of the sensor. [100] Therefore, supraphysiological 
levels of epinephrine will induce a color shift on the optimized paper sensor detectable 
with UV-visible spectroscopy but normal physiological values will not. This supports the 
diagnostic use of the sensor in a real-world situation. Furthermore, since the UV-vis shift 
is correlated to the concentration of target analyte, this method may also be used as a 
quick determinant of epinephrine levels in the patient. 
The use of a cellulose-based paper approach provides a simple, easy and 
equipment free tool for sensing biomolecules. Of note, the paper did not interfere with the 
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sensing mechanism but further enhanced the color variance by providing high contrast 
background [68, 133]. The test result was stable for up to 30 min and indicates high 
sensitivity for the epinephrine molecule. 
 
 
Figure 22: Colorimetric analysis of AuNPs-aptamer in the presence of different 
concentration of epinephrine (9 µM, 4.5 µM, 1.8 µM, 9 µM, 900 nM, 90 nM, 9 nM, 900 
pM, 90 pM) on a hydrophobic paper based substrate.  The corresponding ratio of 
blue/red colour values of the AuNPs spots are represented in the figure. The columns 
represent the mean values whereas the small error bars represent the standard 
deviation in the different set of experiments. The change in colour was observed at 9 
nM with a significant increase in B/R value from 0.58 to 0.65. 
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2.5 Summary 
To the best of our knowledge, the present work is the first established colorimetric 
detection of epinephrine using an aptamer based approach. The minimum amount of 
epinephrine detected using AuNPs-apt system was 9 x 10-9 M on a paper based sensor 
and 0.9 x 10-9 M using UV-Visible spectroscopy. While all the parameters tested in this 
current study played an important role in the functionality of the paper-based sensor, the 
size and morphology of the AuNPs proved most crucial in controlling the detection limit. 
It was observed that bigger size particles with greater negative charge are too stable and 
therefore not suitable for an efficient sensor. This optimized AuNPs-apt sensor approach 
can be used for the detection of any biomolecule so long as the bound aptamer is 
designed to detect the target analyte. Successful implementation of this paper-based 
sensor will provide easy, rapid, portable and inexpensive point-of-care testing which will 
revolutionize the world of bio-diagnostics and bio-imaging. 
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CHAPTER 3: HIGHLY SELECTIVE APTAMER BASED ORGANIC 
ELECTROCHEMICAL BIOSENSOR WITH PICO-LEVEL DETECTION 
 
3.1  Introduction 
Organic electrochemical transistors (OECTs) show great potential in the field of 
biosensors due to their low operating voltages and signal amplification. Over the past 30 
years, OECTs have been utilized to detect numerous metal ions [134], small biomolecules 
[135, 136], proteins [137], oligonucleotides [138] and many other biological reagents [139-
142]. The cost effectiveness, availability, simplicity and portability of OECTs give them an 
edge over other  traditional optical techniques used as biosensors in diagnosis [143]. The 
OECT device based on PEDOT: PSS (poly(3,4-ethylenedioxythiophene) polystyrene 
sulfonate) has shown a higher transconductance as compared to silicon based transistor 
and also outperformed electrolyte-gated graphene [144, 145]. PEDOT: PSS based 
OECTs offer a means of developing highly efficient point-of-care testing tool which exhibit 
high sensitivity and selectivity for the detection of molecule of interest.  
A typical OECT device consists of a source-drain channel which is connected by 
an organic semiconducting material such as PEDOT: PSS as an active layer. The device 
can be switched on or off by varying the channel current that flows through the active 
layer controlled by an applied voltage from the third electrode called gate [146]. The 
The work presented in this chapter has been published in  
Biosensors and Bioelectronics 117 (2018) 40–46; DOI: 10.1016/j.bios.2018.05.031  
Reproduced by permission of Elsevier 
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effective gate voltage depends on the potential difference between the PEDOT: 
PSS/electrolyte and gate/electrolyte interface. The conductivity of the active layer can be 
modulated through doping/de-doping effects of the electrochemical reactions occurring in 
the device [147]. Therefore, any charge transfer reaction which alters the surface potential 
of the gate electrode causes a significant change in channel current which can be 
measured with high accuracy using simple instrumentation [148]. The transducing 
properties along with high specificity in these devices make them excellent candidate in 
biosensing especially in healthcare industry where detection at an early stage can be 
extremely helpful. 
The application of OECT device as a biosensor [134-142] relies on the use of some 
biorecognition element such as enzymes, antibodies, oligonucleotides etc. which can 
transduce an electrochemical change in the presence of molecule of interest. Aptamers 
have been extensively used as the biorecognition molecule in the field of colorimetric 
[149], [122], electrochemical [150], spectrophotometry [151], [152], mass-sensitive [153], 
and electrophoretic sensing [154], [155]. Aptamers are short DNA or RNA chains which 
selectively bind to a target molecule with high affinity. As compared to antibodies and 
enzymes, aptamers are resilient to heat, pH variation and chemically harsh conditions 
which makes them more efficient for practical applications [137]. The process of SELEX 
(Systematic Evolution of Ligands by Exponential Enrichment) is used to design and select 
appropriate aptamers for the target molecules [138]. Once the aptamers are designed, 
these can be synthesized in large quantities with high purity and reproducibility [153]. 
Thus, the use of aptamers offers a method for sensitive, selective, and affordable 
biomolecule detection. 
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 In this study, an ultra-sensitive label free aptamer based OECT device has been 
developed to detect the presence of catecholamine epinephrine. Epinephrine, commonly 
known as Adrenaline, is responsible to prepare the body for “fight or flight” response by 
accelerating the heartbeat, stimulate glucose production [156], dilate pupil [157] etc. It is 
generally administered in case of severe emergency situations such as cardiac attack, 
anaphylactic shocks or asthma attacks. The physiological level of epinephrine in a human 
body under normal conditions ranges form 120-200 pM [158] which shoots up in 
conditions like pulmonary edema [159], Takotsubo cardiomyopathy [160], myocardial 
infarction [161], arrhythmias [162] and other thyroid problems [158]. Therefore, detection 
of epineprhine has significance in a variety of applications ranging from severe allergy 
reactions, anti-doping regulations to treatments for cardiac attacks. The detetction of such 
small molecules has been done using various spectroscopic and chromatographic 
techniques [104, 149, 163-168] which has given impressive results, however these 
techniques are generally time consuming, complex and require skilled labour. The 
present approach introduces a highly efficient sensor providing a means for real-time 
detection in a timely and efficient manner and requires very small volume of the sample 
to run.  
 Figure 23A illustrates the aptamer based OECT device fabricated for the detection 
of epinephrine molecule in the present study. The gate, source, and drain electrodes are 
labelled as 1, 2, and 3 respectively. The source and drain electrodes are bridged by an 
organic semiconductor layer PEDOT: PSS, shown by the translucent, dark blue rectangle. 
The epinephrine specific aptamers are immobilized on to the gate electrode by thiol 
bonding. A PDMS mold is used to contain the electrolyte solution which ensures direct 
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flow of current between the aptamer modified part of the gate (labelled as 4) and the 
PEDOT: PSS layer. The working principle of the current approach is based on the 
interaction of aptamers with epinephrine which enables the oxidation of the molecule in 
the vicinity of gate electrode. The oxidation generates 2e- in the solution which produces 
Faradaic current in the device. The screening of the negative charge of aptamers along 
with the production of Faradaic current results in an increase in the effective gate voltage 
and decrease in the overall channel current which is measured as output signal. The 
present approach leads to a highly sensitive and specific label-free sensor which exhibits 
time and cost effectiveness, easy readout signals and utilizes off-the-shelf electronics. 
 
3.2  Methods & Materials  
3.2.1  Chemical Reagents  
Epinephrine binding thiolated 32-mer aptamers were synthesized and provided by 
BasePairBio Company (Pearland, TX). Chemicals such as epinephrine, 3,4-
dihydroxyphenylacetic acid (DOPAC), tyrosine, glycine, dopamine, cysteine, L-ascorbic 
acid, tryptophan, PEDOT: PSS, and DMSO (dimethylsulfoxide) used during testing were 
purchased from Sigma-Aldrich (St. Louis, MZ). The TCEP (Tris (2-carboxyethyl) 
phosphine), Tris hydrochloride, phosphate buffered saline, and magnesium chloride that 
were utilized to make folding and resuspension buffers were also purchased from Sigma-
Aldrich (St. Louis, MZ). LOR, Shipley microposit S1813, MF-CD-26 developer, and PG 
remover used for photolithography and pattering of the electrodes were purchased from 
Microchem (Westborough, MA). Gold pellets for deposition of gold electrodes were 
obtained from Kurt J. Lesker Company (Jefferson Hills, PA). The silicon wafers with 
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orientation (100) were purchased from Wafer World Inc. (West Palm Beach, FL). For all 
experiments in the study, DNAse – RNAse free tips, vials and water purchased from 
Thermofisher (Waltham, MA), were used to avoid nuclease contamination. 
 
3.2.2 Fabrication and measurement of OECT- based sensor 
The OECT device used in the present study (Figure 23A) was constructed on silicon 
wafer. First, the wafer was cleaned by rinsing with acetone, isopropanol, and water. The 
wafer was dried by using nitrogen followed by a 30 second bake at 120°C. To begin the 
fabrication process, the wafer was coated with a 10 nm thick aluminum oxide layer by 
using an Atomic layer deposition system. The deposition rate was kept at 0.1 nm per 
cycle for a total of 100 cycles at 150°C. The aluminum oxide layer ensured electrical 
insulation of the silicon.  
The following photolithography steps were conducted in a clean room: 
A. The wafer was coated with LOR by spin coating at 3000 rpm for 50 seconds 
followed by a 5 min bake at 175°C.  
B. After cooling, the wafer was coated with Shipley S1813 by spin coating at 5000 
rpm for 50 seconds followed by a 2 min bake at 120°C.  
C. The wafer was then exposed to UV at a wavelength of 275 nm for 20 seconds 
under a mask which was used to pattern the electrode onto the wafer. 
D. After another bake for 2 minutes at 120°C, the wafer was developed in MF-CD-26 
developer for 1 minute with constant agitation.  
E. Finally, the wafer was rinsed with deionized water, blow dried with nitrogen and 
baked for 30 seconds at 120°C. 
53 
 
F. To deposit gold, an AJA e-beam evaporator was used. First, 3 nm layer of titanium 
was deposited to enhance the adhesion of the gold to the silicon wafer. Then, 50 nm layer 
of gold was deposited. After deposition, LOR, Shipley, and unwanted sections of gold 
were removed by ultrasonicating the wafer in PG remover for 20 minutes.  
G. The end result left gold deposited only on the sections patterned by UV exposure, 
creating the gold electrodes for OECT. The entire channel length and the width of the 
electrodes were 2.6 cm and 0.5 cm respectively. The diameter of the gate electrode was 
kept at 0.4 cm. 
 
3.2.3 PEDOT: PSS deposition 
The PEDOT: PSS layer was deposited using a similar protocol as gold deposition. After 
the transistor fabrication process, the transistor was rinsed with acetone, isopropanol, and 
water, and then properly dried. Shipley microposit S1813 was deposited by spin coating 
at 5000 rpm for 50 seconds followed by a 2 min bake at 120°C. Again, UV exposure for 
20 seconds was used for patterning, but a different mask was used which only patterned 
the junction between the source and drain electrodes. The wafers were developed in MF-
CD-26 developer for 1 minute with constant agitation. The wafer was rinsed with 
deionized water, blow dried with nitrogen and baked for 30 seconds at 120°C.  
The active layer of PEDOT: PSS was deposited using the same photolithography 
protocol. The solution of PEDOT: PSS was first filtered using a 0.22 µm membrane filter 
and modified with the addition of 5% by volume DMSO to decrease its solubility in 
aqueous solutions and increase its conductivity [169]. The filtered solution was spin 
coated onto the patterned wafer, followed by baking at 120°C for 40 minutes. The result 
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was a thin, translucent layer of the active material deposited at the junction of the channel. 
The thickness of the layer as measured using Dektak Profilometer was around ~200 nm. 
The optimization of PEDOT: PSS deposition for uniform thickness, surface area and 
shape ensured consistent electrical and physical properties and less variability between 
different samples.  
 
3.2.4 Aptamer Preparation and Immobilization 
The lyophilized epinephrine binding aptamers were dissolved in suspension buffer (TE 
buffer, 0.1 mM EDTA, 10 mM Tris HCl, pH 7.5) to achieve a concentration of 100 µM. 
The aptamers were then aliquoted into smaller volumes and stored at -20°C for long term 
storage. To prepare the aptamers for conjugation, a standard protocol of folding and 
reducing steps was followed. The aptamers were diluted using the folding buffer (1 mM 
MgCl2 and 0.01 M PBS, pH 7.5) to acquire the working concentration and incubated for 5 
min at 95°C. The aptamers were then allowed to cool at room temperature for 15 min so 
that they can attain their folded conformation which enables binding to the analyte 
molecule. Before immobilization the aptamers were reduced using TCEP which cleaves 
the disulphide bonds and forms sulfhydryl group which is used for attachment to the gold 
surface. 10 µL of 10 µM reduced aptamers were applied to the gate electrode and allowed 
to incubate for 2 hours at room temperature. The excess aptamer solution was removed 
and the gate electrode was washed multiple times with PBS to remove any unbound 
aptamers from the surface. 
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Figure 23: (A) Schematic illustration of the fabricated aptamer based OECT device on a 
silicon wafer. The source, drain and gate electrodes are labelled as 1, 2 and 3 
respectively. Organic semiconducting layer of PEDOT: PSS is used as an active layer 
to bridge the channel and is represented by blue translucent rectangle. The magnified 
image of the gate electrode shows the immobilization of aptamers with help of thiol 
bonding. Further, the formation of epinephrine-aptamer complex upon addition of the 
epinephrine and the oxidation of epinephrine on the aptamer modified gate electrode 
has been shown. (B): Output characteristics (ID vs VD) of the aptamer based OECT 
device measured in pure PBS solution in the absence of epinephrine at VG values of 0, 
0.2, 0.4, 0.6, 0.8 and 1.0 V (from top to bottom). (C): Transfer characteristics (ID vs VG) 
of the OECT device measured in PBS solution before and after immobilization of the 
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aptamers on the gate electrode at VD = +0.1 V. The immobilization of the aptamers 
caused a right shift in the VG curve and the difference is measured out to be 46 mV.  
 
 
 
 
 
3.2.5 Testing Apparatus 
The electrical characteristics of the device were studied by a Keysight B2902A Precision 
Source and Measurement Unit controlled by EasyEXPERT software. The Keithley source 
meter was connected to the electrodes to apply and measure both voltage and current 
through the device simultaneously.  During testing, a PDMS gel mold was used to contain 
the electrolyte solution between the aptamer modified part of the gate electrode and 
channel (Figure 23A, labelled as 4). The mold was shaped to ensure that the solution 
only contacted the PEDOT: PSS and the aptamer conjugated part of the gate electrode.  
 
3.3 Results 
3.3.1 Output characteristics 
The output characteristics (Channel current, ID vs source-drain voltage, VD) of the present 
OECT device at varying VG from 0 to +1.2 V along with a negative bias at VD is shown in 
Figure 23B. ID decreases with the increase in the gate voltage, VG which is a typical 
response of PEDOT: PSS based OECT device operating in depletion mode (increase 
gate voltage decreases the channel current) [170], [171]. The positive voltage applied at 
the gate induces cations from the electrolyte into PEDOT: PSS and compensate for the 
negative sulphonate anions present on PSS. This results in de-doping of the 
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semiconducting layer causing a decrease in the hole density which in turn decreases the 
overall channel current. The de-doping in PEDOT: PSS is reversible in nature and the 
layer attains its original state when the gate voltage goes to zero [172]. 
 
 
3.3.2 Aptamer functionalization  
The functionalization of gate electrode with aptamers was confirmed by measuring the 
absorbance intensity of the applied aptamer solution before and after incubation. A 
significant decrease in absorbance intensity at 260 nm (A260) was observed and 
quantitative analysis was done by plotting the calibration curve. The packing density for 
the attached aptamers was calculated to be 2.2 × 1012 aptamers per cm2. (Figure 24 (A, 
B)). The higher packing density of the aptamers hinders the binding of aptamer-analyte 
due to the close packing of the strands whereas the lower packing density results in low 
performance because of the less binding sites available. The packing density of 2.2 x 1012 
lies near the optimum packing density (1.6 x1012) as reported in the previous studies [173, 
174].  
The effect of addition of aptamers over Au gate electrode was also examined 
through output characteristics. Figure 23C shows the ID versus VG characteristics at a VD 
of +0.1 V. The measurement was done in same electrolyte solution (pure PBS) before 
and after functionalization with epinephrine aptamers. A significant increase in channel 
current was observed after functionalization of gate electrodes. As reported previously, 
the performance of an OECT depends extensively on the surface potential and 
electrolyte/gate interface capacitance of the gate electrode [171, 175, 176]. Therefore, 
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the immobilization of the aptamers over the gate electrode increased the overall negative 
charge density due to the presence of phosphate backbone which resulted in a decrease 
in the effective gate voltage and thus increase the overall channel current [138, 177, 178].  
 
 
Figure 24: (A) UV-spectra of aptamers at different concentration in PBS solution. (B) 
The absorbance at 260 nm (A260) as a function of concentration of aptamers. Washed 
aptamers showed an absorbance of 2.4 which corresponds to 6.3 µM concentration. 
 
 
 
3.3.3 Transfer characteristics 
The transfer characteristics (ID vs VG) were studied at VD= +0.1V by using PBS as the 
electrolyte. The aptamers conjugated gate electrode of the device was incubated with 
epinephrine solution (90 pM, 900 pM, 9 nM, 90 nM, 900 nM, 9 µM, 90 µM, 900 µM) for 10 
min and then washed off to remove unbound epinephrine. Figure 25A shows the channel 
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current (ID) vs. gate voltage (VG) transfer curve at various concentrations of epinephrine. 
It was found that as the concentration of epinephrine increased from 90 pM to 900 µM, 
the transfer curve showed a distinct trend towards lower gate voltage. The change in gate 
voltage (∆VG) as a function of concentration of epinephrine (log[Epi]) was plotted with the 
help of transfer characteristics (ID vs VG) shown in Figure 25B. The device shows a 
constant increase in |ΔVG| with increase in the concentration of epinephrine and a linear 
behavior can be seen from 90 pM to 900 nM. The ∆VG becomes constant due to saturation 
of aptamer binding sites at higher concentration of epinephrine (>900 nM). The detection 
limit of the system was found to be 90 pM which showed a change of 53 mV upon addition 
of epinephrine.  
 
Figure 25:(A) Transfer characteristics (ID vs VG) of the aptamer based OECT device in 
the presence of different concentration of epinephrine at VD=+0.1V in PBS solution. A 
constant left shift in the VG with increasing amount of the epinephrine can be seen. (B) 
The change in VG of the OECT induced by interaction of epinephrine with the aptamers 
as derived by the transfer characteristics. The inset shows the fitting of the linear range 
(90 pM to 900 nM) having an R2 value of 0.98.  
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3.3.4 ID -time characteristics 
In order to monitor the real-time response of the aptamer modified OECT device, channel 
current, ID vs time curve was plotted at VD= +0.1V and VG= +0.7V as fixed parameters. 
The dependence of the source-drain current on the consecutive additions of epinephrine 
at various concentrations (90 pM-90 µM) is shown in Figure 26A. It can be seen that the 
addition of epinephrine at consecutive time intervals caused constant drops in the current 
which was seen almost immediately after the addition. It was also observed that along 
with the drop in current, there was slight increase in the channel current before the next 
addition. The binding of epinephrine to the aptamer is a dynamic process. The process 
includes constant association and dissociation of the molecules which takes a few 
seconds to equilibrate so that the system can attain lowest energy state. Therefore, 
instead of a straight curve, slight elevations were observed at lower concentrations (90 
pM, 900 pM, 9 nM and 900 nM). At higher concentrations, sharp drop in the channel 
current was observed after the addition. The change in channel current (|∆ID|) gives a 
linear dependence on logarithmic function of concentration of epinephrine as shown in 
Figure 26B.  
 
3.3.5 Selectivity Assay Results 
To test the selectivity of the aptamer based OECT sensor, an ID vs t test was conducted 
to observe the device response to biomolecules other than epinephrine. The interfering 
species selected were DOPAC, tryptophan, tyrosine, glycine, cysteine, dopamine, and 
ascorbic acid. These species were chosen either due to their structural similarity to 
epinephrine, or their similar biological functions. Figure 26C demonstrates device 
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response in terms of change in ID with subsequent addition of interfering species at a time 
interval of 5 min. The sensor displayed a sharp decrease in ID after the addition of 
epinephrine whereas for other reagents, very slight/no change in the current was seen.  
 
Figure 26: (A) The normalized time-current (ID/I0 versus t) characteristics of the present 
OECT device at VD= +0.1 V and VG= +0.7 V as fixed parameters. Addition of 
epinephrine was done at subsequent intervals of 13 minutes at a concentration of 90 
pM, 900 pM, 9 nM, 90 nM, 900 nM, 9 µM, 90 µM - left to right. The increase in 
epinephrine resulted in constant drops in the channel current. (B) The change in 
channel current (mA) is plotted as a function of epinephrine concentration (90 pM-90 
µM). A linear response was observed in the presence of epinephrine concentration with 
R2 value of 0.96. Error bars represent the standard deviation from the mean value. The 
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large error bar at 90 µM is due to the saturation of aptamer binding sites. (C)  The 
normalized current response as a function of time (ID vs t) in the presence of interfering 
species (10 µM). The addition was done at an interval of 5 min in the order of DOPAC 
(1), tryptophan (2), tyrosine (3), dopamine (4), glycine (5), cysteine (6), ascorbic acid (7) 
and epinephrine (8).  A sudden drop in the current was seen after the addition of 
epinephrine (1 µM). (D) A schematic illustration of the change in VG before and after 
addition of epinephrine. To maintain the same effective voltage in the device, the VG 
decreases to offset the Faradaic current produced due to the oxidation of epinephrine. 
VG1 represents the device with only immobilized aptamers and VG2, VG3 represents the 
new gate voltage with increasing concentration of epinephrine respectively. VG1 >VG2 > 
VG3. 
 
The concentration of epinephrine used was 1 µM whereas 10 µM for the interfering 
species.The addition of cysteine and dopamine caused slight decrease in the current as 
can be observed at 22 min and 32 min. Interference from dopamine can be due to high 
structural similarity between epinephrine and dopamine. The thiol group present in the 
cysteine molecule could have interfered in the output signal as thiol is known to have a 
high affinity for the gold surface. Overall, the presence of aptamers suppressed the 
nonspecific binding of the interfering species at the gate electrode. 
 
3.4 Discussions 
The working of an OECT device depends largely on the change in conductance of the 
active layer due to the electrochemical doping/de-doping of the cations from the 
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electrolyte controlled by variation in the effective gate voltage (∆𝑉𝐺
𝑒𝑓𝑓
) of the device. The 
∆𝑉𝐺
𝑒𝑓𝑓
depends on the potential difference between the gate-aptamer/electrolyte and 
PEDOT: PSS/electrolyte. In the present study, the ∆VG
eff is dependent only on the change 
in the potential at gate-aptamer/electrolyte interface since epinephrine-aptamers complex 
are formed on the gate electrode. The channel current of an OCET device at a certain VG 
and VD is given by the following equation.  
𝐼𝐷 =
𝑊𝑞𝜇𝑡𝑝0
𝐿𝑉𝑃
(𝑉𝑃 − 𝑉𝐺
𝑒𝑓𝑓
+
𝑉𝐷
2
) 𝑉𝐷, (𝑤ℎ𝑒𝑛 |𝑉𝐷| ≪ |𝑉𝑃 − 𝑉𝐺
𝑒𝑓𝑓
|)           (1) 
𝑉𝑃 =
𝑞𝑡𝑝0
𝐶𝑖
 
     𝑉𝐺
𝑒𝑓𝑓
= 𝑉𝐺 + 𝑉𝑜𝑓𝑓𝑠𝑒𝑡
                     (2) 
where W and L represents the width and length of the channel, t is the thickness of the 
organic semiconductor layer (PEDOT: PSS), q is the electronic charge (1.6 x 1019), μ is 
the hole mobility, Ci is the effective gate capacitance and p0 is the initial hole density of 
the channel before applying VG. VP is the pinch-off voltage and VD is the source-drain 
voltage. The ∆𝑉𝐺
𝑒𝑓𝑓
represents the effective gate voltage in the device and VOffset is the 
change in potential due to potential difference between the gate/electrolyte and PEDOT: 
PSS/electrolyte interface. 
 After the binding of epinephrine to the aptamers and application of positive voltage 
at the gate electrode, the electro-oxidation of epinephrine occurs. The oxidation causes 
release of 2e- in the solution which produces Faradaic current at the gate/electrolyte 
interface.  
Epinephrine → Epinephrine quinone + 2H+ + 2e- 
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As a result, there is a decrease in the potential drop which increases the effective gate 
voltage of the device. This change in effective gate voltage further decreases the overall 
channel current as given in Equation 1. The change in effective gate voltage due to the 
electro-oxidation of epinephrine is given by: 
   𝑉𝑜𝑓𝑓𝑠𝑒𝑡 =
2.3(1+𝛾)𝑘𝑇
𝑛𝑒
log[𝐸𝑝𝑖] + 𝑐𝑜𝑛𝑠𝑡𝑎𝑛𝑡     (3) 
where 𝛾 is defined as the ratio between the capacitances of the channel (CC) and the gate 
(CG) with respect to the electrolyte, 𝛾 = CC/CG; n (=2) is the number of electrons released 
during the oxidation, k and T represent the Boltzmann constant and room temperature 
and log[Epi] is the logarithmic function of concentration of epinephrine. As shown in 
Figure 25B, the slope of the fitted curve was found out to be 80 mV/decade in the linear 
region and thus the value of 𝛾 was 1.24.  The left shift in the ID vs VG curve with increase 
in the concentration of epinephrine, [Epi] is occurring due to the change in VOffset value 
which is directly proportional to the concentration of epinephrine as given in Equation 3. 
At higher concentrations of epinephrine, the VOffset becomes constant as the aptamer 
binding sites becomes saturated with epinephrine. The unbound epinephrine molecules 
were washed off before measuring the transfer characteristics. Therefore, the present 
sensor follows linear dependence on epinephrine concentration in the 90 pm-900 nM 
concentration regime.  
Figure 26D represents the working of the present OECT device. As discussed 
previously, the immobilization of the aptamers introduces negative charge on the gate 
electrode which decreases the surface potential. To maintain the same effective voltage 
in the device, the VG increases and a shift in the transfer curve to the right side is observed 
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(Figure 23C). However, upon the addition of epinephrine, the negative charge is 
balanced by the positively charged epinephrine (pKa 8.02), the overall effective gate 
voltage increases. To balance this extra potential change, the VG decreases and curve 
shifts to left side (Figure 25A). The change in VG showed a linear dependence on the 
concentration of the epinephrine molecule in the range of 90 pM to 900 nM after which it 
starts saturating. The synergistic effect of the binding event of aptamers along with the 
oxidation of the epinephrine molecule enhances the ∆𝑉𝐺
𝑒𝑓𝑓
as a function of concentration 
of epinephrine which amplifies the change in current and therefore the sensitivity of the 
present OECT device.   
 The addition of epinephrine on the bare gate electrode (no aptamers) was also 
studied with the help of real time ID response curve as shown in Figure 27. The plot shows 
no change in the current upon addition of epinephrine at 100 pM, 1 nM, 10 nM until 100 
nM when a huge drop in current was observed. The decrease in the current is due to 
increased concentration of epinephrine in the electrolyte solution which facilitated the 
oxidation of epinephrine. The binding of epinephrine to the aptamers not only changes 
the surface potential of the gate electrode but also ensures the accumulation of 
epinephrine molecules in the vicinity of the gate electrode. The increased concentration 
of epinephrine around gate expedites the oxidation of the molecule and hence, maximizes 
the sensitivity of the sensor. Therefore, the presence of aptamers contributes to the high 
specificity of the sensor and also increases the detection limit by an order of atleast 103 
magnitude. 
So far it has been established that the detection limit of the current approach is 90 
pM. The physiological level of epinephrine for a healthy individual is in the range of 120-
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200 pM which increases in conditions like hyperthyroidism (359 ± 150 pM) and 
hypothyroidism (373 ± 150 pM) [158]. The increase in epinephrine level is also prominent 
in Takotsubo cardiomyopathy and Killip Class III myocardial infarction which averages 
the level to 6.9 nM and 2.1 nM after 1 or 2 days respectively [132]. Quantitative analysis 
of epinephrine can be done using the present approach in the range of 90 pM to 900 nM 
which can be used for the early detection of pathological conditions as described above. 
Table 2 summarizes the different approaches used for the detection of epinephrine and 
their respective detection limits as listed in the literature.  2015 Mak et al. study reported 
a comparable detection limit of 100 pM [165] . The study is based on the electrical 
oxidation of epinephrine molecule using Pt based gate electrode modified with nafion and 
single walled carbon nanotube. The interference from ascorbic acid was seen at 100 nM 
whereas the present sensor showed no response to ascorbic acid even at a concentration 
of 10 µM. Selectivity is essential for real-world sensors to avoid the need for costly and 
time-consuming purification steps. Therefore, the aptamer-based OECT sensor 
presented in this work exhibits great potential in the real-world applications which gives 
fast and easy-to-read signals. 
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Figure 27: The normalized time-current (ID/I0 versus t) characteristics of the present 
OECT device in the presence of different concentration of epinephrine on bare Au gate 
electrode. The addition was done at an interval of 10 min in the order of 100 pM, 1 nM, 
10 nM and 100 nM in the presence of PBS as electrolyte. The plot shows no change in 
the current upon addition of epinephrine at 100 pM, 1 nM, 10 nM until 100 nM when a 
huge drop in current was observed. 
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Table 2: Comparison of different techniques used for the detection of epinephrine and 
their respective detection limits. 
Method Detection limit References 
Colorimetric 900 pM [149] 
Capillary Electrophoresis 100 nM [163] 
Ion chromatography 5.9 nM [167] 
HPLC-MS 56 nM [104] 
Differential Pulse Voltammetry 90 nM [168] 
Chemiluminescence 1.1 µM [164] 
Differential Pulse Voltammetry 30 nM [166] 
OECT 100 pM [165] 
OECT 90 pM Present method 
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3.5 Summary 
A. A PEDOT: PSS based OECT sensor functionalized with aptamers was fabricated to 
detect the presence of epinephrine molecule. The high binding affinity of the aptamers 
towards epinephrine and the electro-oxidation of the molecule in the vicinity of gate 
electrode allow the present aptasensor with 90 pM limit of detection. The addition of 
epinephrine on the gate electrode resulted in a significant decrease in the channel current 
which was observed in both ID vs VG and ID vs time characteristics. In addition, 
experiments were conducted against common interfering agents to determine the 
selectivity of the OECT sensor. The device showed an instant drop in current upon 
addition of epinephrine as opposed to the other interfering molecules, indicating highly 
selective nature of the sensor. The inclusion of aptamers resulted in an increase of 
sensitivity by 103 magnitude and high specificity towards epinephrine molecule. The 
present approach provides an easy, simple, rapid method for detecting epinephrine, 
however more work needs to be done in order to test the repeatability and reusability of 
the sensor. The future work will be aimed at extending the current approach to develop 
flexible sensor capable of detecting various biomolecules by utilizing different aptamers 
on a single platform. The present work lays the ground for developing a wide range of 
personalized point-of-care testing tools for therapeutic applications. 
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CHAPTER 4: MULTIPLEX VIRAL DETECTION SYSTEM BASED ON 
APTAMERS INTEGRATED MICROFLUIDIC CHANNEL 
 
4.1  Introduction 
Zika virus (ZIKV) is a mosquito-borne virus which is vectored by Aedes family (aegypti 
and albopictus) and is known to pose a serious threat to the population worldwide. Nearly 
440k-1300k cases associated with microcephaly and central nervous system 
abnormalities were reported during Zika outbreak in Brazil in 2015[179, 180]. Besides 
Brazil, cases associated with Zika infection have also been reported in 66 other countries 
till date [181]. The world health organization declared a Public Health Emergency of 
International Concern (PHEIC) in 2016 due to the increase in microcephaly cases and 
neurological disorders that were generated by the Zika virus.[182] More than 5k cases 
since 2016 have been confirmed in United States alone as confirmed by Pan American 
Health Organization[179]. The transmission of Zika occurs through infected mosquito bite, 
in utero mother to fetus and sexual contact. Zika infection is usually asymptomatic, 
however sometimes non-specific symptoms such as rash, fever, headache, vomiting and 
joint pains of varying degrees can be observed [183, 184]. These symptoms overlap 
significantly with other flaviviruses infection such as Chikungunya (CHIKV). Due to a 
shared vector as well as non-specific symptoms, adequate diagnosis of Zika at an early 
stage poses a serious challenge specially in resource constrained communities where 
both the viral infection are endemic.  
 The current diagnostic tools for the detection of Zika virus depend mostly on RT-
PCR (reverse transcription polymerase chain reaction)[183], RT-LAMP (reverse-
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transcription loop-mediated isothermal amplification)[185-189] and RT-RPA (reverse 
transcription recombinase polymerase amplification)[190] coupled with external power 
source and a display unit such as smart phone for an easy readout signal.[191-197] These 
techniques often require expensive instrumentation, skilled labor and sometimes faces 
major disadvantage of false negative/positive results arising from new strains or 
contamination.[198] Other methods for Zika diagnosis such as IgM-capture ELISA and 
plaque reduction neutralization test (PRNT) face a major challenge of cross-reactivity with 
other flaviviruses[198] leading to ambiguous results. Therefore, there is a dire need for 
the development of novel, compact and passive point-of-care (POC) testing tools which 
can provide multiplexed diagnosis in a rapid and cost-effective manner. 
  To this end, we have fabricated a flexible, portable, easy-to-use aptamer based 
microfluidic sensor for the multiplex detection of recombinant Zika and CHIKV envelope 
proteins. Aptamers are short single-stranded oligonucleotides that are designed using in 
vitro SELEX (Systematic Evolution of Ligands by Exponential enrichment) process to bind 
to a specific target with high specificity and affinity. Aptamers offers several advantages 
over antibodies such as stability in harsh environment, ease of synthesis and 
functionalization, high batch to batch consistency and wide variety of targets.[199-202] 
The use of microfluidic platform allows for the manipulation of fluids at the micron-scale 
and are used to implement operations that require large, expensive equipment onto a 
micro-sized device.[203, 204] The compatibility of polydimethylsiloxane (PDMS) with 
microfluidic fabrication offers flexibility and optical transparency which enhances the 
colorimetric signal obtained in the presence of analytes produced during the test. 
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Figure 28: Schematic representation of the current approach based on sandwich assay 
for the detection of multiple viral proteins on a single platform. The surface is first 
conjugated with a linker molecule, PMPI which attaches to thiolated end of the aptamers 
(1). Control site is blocked with BSA molecule. The infected sample containing viral 
protein is introduced in the channel where the specific aptamers bind to their specific 
proteins (2). AuNPs conjugated with aptamers is then allowed to bind to a different 
epitope on the protein forming a sandwich morphology (3). If no protein is present, all 
the AuNPs will be washed off. In the end, silver reagents are introduced in the channel 
which deposits over the surface of AuNPs giving a colorimetric signal to the presence of 
viral protein (4). 
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The current sensor depends on the engineered sandwich assay with Aptamer1-Antigen-
Aptamer2 for the detection of ZIKA and CHIKV antigens (Figure 28). The Aptamer1 is 
immobilized on the microfluidic channel which captures the incoming protein present in 
the infected samples. The Aptamer2 conjugated with gold nanoparticles (AuNPs) is used 
to report the presence of antigen by generating an output signal in the form of color 
change. Development of silver around the AuNPs results in dark gray color depending on 
the concentration of protein which amplifies the color change in the channel. The major 
advantage of using antigen-capture sandwich assay is high sensitivity and colorimetric 
detection capabilities with crude sample preparation.[205] The approach is similar to the 
ELISA technique but avoids the use of expensive plates and plate readers, and is very 
easy to handle. Also, the replacement of antibodies with the aptamers makes this 
technique more robust while maintaining the accuracy and reliability of the approach.  
 
 
4.2 Materials and Methods 
4.2.1 Chemical reagents 
Recombinant Zika envelope protein (ZKV-005) and Chikungunya type E1 (CHI-001) were 
obtained from Prospecbio (Israel). The protein samples were provided to BasePair 
Biotechnologies (Pearland, TX) for a custom-made set of aptamers. The aptamers 
showing highest binding affinity were used for experimentation. Aptamer folding buffer, 
reducing buffer and resuspension buffer were also provided by Basepair Biotechnologies 
to prepare the aptamers for immobilization. Other chemicals such as Gold(III) chloride 
trihydrate, trisodium citrate, phosphine buffered saline tablets, sodium hydroxide, 
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hexamethyldisilazane (HMDS), acetonitrile and magnesium chloride (MgCl2) were 
purchased from Sigma-Aldrich (St. Louis, MZ). PMPI (p-maleimidophenyl isocyanate) 
used for the functionalization of PDMS was obtained from Thermofisher (Waltham, MA). 
Dow Corning Sylgard 184 Silicone Encapsulant Clear Kit for the fabrication of microfluidic 
channels was purchased from Ellsworth (Germantown, WI). SU8 and SU8 developer 
used during photolithography was purchased from MicroChem (Westborough, MA). The 
masks were printed by CAD/Art Servies (Bandon, OR). The silver enhancement kit was 
purchased from Cytodiagnostics (Burlington, ON). Silicon wafers were obtained from 
Waferworld Inc. (West Palm Beach, FL). The entire study was done using DNAse-RNAse 
free water, vials and pipette tips obtained from Thermofisher.  
 
4.2.2 Fabrication of microfluidic channel 
Fabrication of Master mold: PDMS based microfluidic channels were fabricated using 
a soft lithography technique. [206] The silicon wafers were cleaned thoroughly by rinsing 
with acetone, isopropanol and water, followed by nitrogen blow. These were kept at 80oC 
for 15 min to evaporate any residual water. After cleaning, the wafers were pretreated 
with HMDS overnight to improve the adhesion between the photoresist layer and wafer 
surface. The HMDS treated wafers were deposited with SU8 photoresist for the 
development of master mold. The wafer was centered on rotating stage of the spin coater 
and a dollop of SU8-2050 was poured in the center. SU-8 was spincoated over the wafer 
at 2500 rpm for 50 sec which gave an average thickness of 70 m of the layer. After 
spinning, the wafer was soft baked at 65oC for 3 min followed by 95oC for 8 min. The 
wafer was allowed to cool at room temperature for atleast 5 min. The next step in the 
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lithography is to transfer the pattern of the mask onto the SU8 deposited Si wafer. The 
mask was placed over the Si wafer in the mask aligner and exposed to UV (275 nm) for 
50 sec. After UV exposure, the silicon wafers were baked for 1 min at 65oC followed by a 
6 min bake at 95oC. Upon cooling, the wafers were developed in copious amount of SU-
8 developer for 5 min, followed by rinsing with Isopropanol. If white streaks were seen, 
the wafers were again kept in fresh developer solution for few seconds and then rinsed 
with IPA. The developed wafers were dried using nitrogen blow and baked at 95oC for 3 
min. The fabricated master molds were silanized using tricholorsilane for 2 hours under 
vacuum to make the peeling step easier. 
 
Development of Microfluidic channels: The PDMS mixture was formed by adding the 
base and cross-linker (provided in the Dow Corning kit) in 10:1 weight ratio in a disposable 
plastic weigh boat. The mixture was thoroughly mixed with a plastic-stir rod until it became 
cloudy and suspended with air bubbles. The air bubbles were removed by placing the 
boat under vacuum in a desiccator and venting it periodically. Once all the air bubbles 
were removed, the PDMS mixture was poured slowly on to the master mold in a petri 
dish. The petri dish was then placed in a pre-heated oven at 65oC for 1 hour to cure. After 
curing, the PDMS hardened over the mold and took the features of the mold as shown in 
Figure 29A. It was then peeled off carefully and individual channels were cut using a 
sharp blade.   
 
Surface treatment of Microfluidic channels: The microfluidic channels were treated 
with 1 mM NaOH solution at room temperature for 16 hours under gentle shaking. The 
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samples were then washed thoroughly with DNase-RNase free water, followed by drying 
with nitrogen blow. After this, PMPI dissolved in acetonitrile (10 mg/ml) was applied onto 
the testing regions and kept for 3 hours at room temperature. The surface treatment of 
PDMS with PMPI offers a free maleimide group which shows high affinity towards thiol 
bond present at the end of aptamers. The samples were washed with acetonitrile and 
working buffer (1 mM MgCl2, 1X PBS, pH 7.5) thrice before conjugating with aptamers.   
 
4.2.3 Preparation of aptamers and immobilization 
The obtained thiolated aptamers (both CHIKV and Zika) were dissolved in resuspension 
buffer to obtain a 100 M stock concentration. The aptamers were diluted to 50 M using 
folding buffer and heated at 95oC for 5 min. Then, these were cooled to room temperature 
for 15 min. This allows the aptamers to fold properly and attain their native conformation 
required for binding to the target molecule. After 15 min, the aptamer solution was mixed 
with the reducing buffer (TCEP) in 1:1 ratio (v/v) to obtain a final concentration of 25 M 
and kept at room temperature for another 20 min. The TCEP is used to cleave the 
disulphide bonds (-S-S-) which allows for free –SH group. The -SH group plays a major 
role in binding of the aptamers to the Gold Nanoparticles as well as PDMS surface.  
 
Immobilization on AuNPs: 13 nm citrate capped AuNPs prepared using standard 
Turkevich method were used in the present study. The aptamers were immobilized on 
AuNPs surface by incubating 1 ml of AuNPs (0.2 mg/ml) with 20 M (10 l) of reduced 
aptamers at room temperature with gentle stirring overnight. The AuNPs solution was 
then centrifuged down (11000 rcf, 11 min) to remove unbound aptamers and 
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resuspended in working buffer. The conjugation of aptamers was confirmed by performing 
gel electrophoresis on the bare as well as aptamer conjugated AuNPs. 
 
Immobilization on PDMS: The prepared aptamers were added directly to the 
functionalized testing zone on the microfluidic channel and allowed to sit for 3 hours with 
gentle stirring. The final concentration of the aptamers used for each testing zone was 25 
M, 20 l. After 3 hours of incubation, the channels were washed gently with working 
buffer to remove unbound aptamers. To avoid non-specific binding of the protein, the 
channels were then passivated using 1% BSA for 1 hour. 
 
 
4.3 Results and Discussion 
4.3.1 Development of microfluidic channel 
The fabricated microfluidic channels were integrated with micro-sized pillars to increase 
the surface area in the testing region. The enhanced surface area ensured more number 
of aptamers in the testing zone which increased the binding sites for the protein 
molecules, thus enhancing the sensitivity of the approach. The SEM analysis shown in 
Figure 29B confirms the presence of pillars in the magnified view of the testing zone. The 
analysis of the vertical and lateral view (inset) indicates that the pillars have an average 
diameter and height of 50 m and 45 m respectively. 
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Figure 29: (A) Fabrication process of microfluidic channels using a Si master mould. 
PDMS is poured carefully and cured at 65oC for 1 hour. Next step shows peeling off the 
layer from the mould and channels being formed in the PDMS layer. (B) Image of a 
single microfluidic channel. SEM image representing magnified view of the testing zone 
showing the presence of pillars with an average diameter of 50 µm. (C) FTIR 
spectroscopy of the microfluidic channel at different steps of functionalization: NaOH, 
PMPI and aptamers treatment. Peaks at 1698 cm-1 and 1531 cm-1 represents amide I 
and amide II bands in PMPI which shows the presence of urethane linkage. (D) 
Schematic representation of the functionalization of the channel using PMPI as the 
linker molecule to immobilize aptamers. (E, F) UV-visible spectroscopy and TEM 
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analysis of the Turkevich method based Gold nanoparticles. Inset shows narrow size 
distribution of the particles in the range of 15-20 nm as measured by DLS. (G) Gel 
Electrophoresis of the bare and aptamer conjugated AuNPs. Migration is observed in 
the aptamer conjugated samples due to the negative charge on the particle surface. 
 
 
4.3.2 Functionalization of Microfluidic channel  
The microfluidic channels were first treated with aqueous solution of NaOH to make the 
surface hydrophilic in nature. The treatment with NaOH introduces hydroxyl group (-OH) 
at the surface which not only improves the flow but also facilitates functionalization of the 
surface with other chemicals.[207-209] The major advantage of using NaOH over 
traditional ozone treatment is the enhanced stability of the samples irrespective of the 
storage condition. In the second step, the -OH groups were allowed to react with PMPI 
which is used as a linker molecule between aptamers and PDMS surface. The isocyanate 
end (-N=C=O) of PMPI interacts with -OH and forms urethane linkage. This renders the 
maleimide end available for coupling with the thiol group present at the end of 
aptamers.[210-212] The schematic of the reaction is shown in Figure 29D. The FTIR 
spectra (Figure 29C) exhibit different characteristic peaks obtained during the surface 
treatment of PDMS with NaOH, PMPI and aptamers. The FTIR spectrum of PDMS-
NaOH-PMPI showed peaks at 1698 cm-1 and 1531cm-1 which corresponds to Amide I and 
Amide II bands (C=O stretching and –N-H bending) respectively.[211, 213, 214] A distinct 
peak at 1585 cm-1 is also observed which points to the presence of C=C in the maleimide 
group. After the immobilization of the aptamers, a significant peak at ~3410 cm-1 is 
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observed which is due to large number of hydroxyl groups present at the end of aptamers. 
A peak at 1648 cm-1 is also seen which indicates the presence of the purine and pyrimidine 
rings in the aptamers.[215] The FTIR data confirmed the immobilization of the aptamers 
over PDMS using PMPI as the linker molecule.  
 
4.3.3 Gold nanoparticles synthesis and functionalization 
The Gold nanoparticles were synthesized using a standard Turkevich method in which 
gold chloride precursor salt is reduced using trisodium citrate at high temperature. The 
characterization of the synthesized AuNPs is shown in Figure 29E and 29F. The TEM 
results indicate that the particles are uniformly distributed and spherical in nature with an 
average diameter of 13 nm. The UV visible spectrum (Figure 29E) shows a distinctive 
absorbance peak at 520 nm which represents the surface plasmon band of AuNPs. The 
particles were conjugated with Zika and CHIKV aptamers using a standard protocol at a 
concentration of 200 nM. The successful conjugation of the aptamers over the AuNPs 
was confirmed by running the particles through 0.5% agarose gel under the influence of 
voltage (Figure 29G). It was observed that the aptamer conjugated AuNPs migrated 
through the gel (red arrow) whereas the bare AuNPs remained in the well (black arrow). 
The migration of conjugated particles is due to the overall negative particle charge 
imparted by the conjugated aptamers, which enables these Apt-AuNPs to be driven 
through the gel in response to the applied voltage. 
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4.3.4 Testing of Microfluidic channel 
The present approach was first tested on a PDMS substrate to examine the sensitivity 
and selectivity of aptamers for the target arboviral envelope proteins. A distinct color 
development was observed from 500 pM of CHIKV envelope protein, which intensified 
with increasing protein concentrations (Figure 30). The approach was then extended to 
the microfluidic channels with a controlled flow rate (80µL/min). The aptamer-conjugated 
microfluidic channels were tested against different concentration (10 fM-1 nM) of both 
CHIKV and ZIKV envelope proteins. Figure 31A shows distinct development of silver in 
the testing zones represented by circles. The ‘+’ and ‘-’ sign indicates the presence or 
absence of the specific arboviral envelope protein in the testing solution. For 0 nM, the 
PBS was spiked with BSA which was used as the negative control to test non-specific 
interactions of AuNPs in the channel. No color development was observed in the negative 
control regions in any of the channels, which indicates high specificity of the Apt-AuNPs. 
Also, for the last two channels, only one viral envelope protein (either ZIKV or CHIKV) 
was injected as per (+) or (-) symbol. It can be seen that ZIKV envelope protein at a very 
high concentration of 10 nM did not interfere with the CHIKV aptamers and vice versa. 
This clearly suggests that the current approach is not only highly sensitive with a detection 
limit of 1 pM but also exhibits high level of selectivity among different arboviruses such as 
ZIKV and CHIKV. 
  The color change in the channels was also measured using an image processing 
software to calculate the CMYK (cyan, magenta, yellow and key) values. The key value 
represents the black color that was used as the measure of silver development in the 
microfluidic channels. The more numbers of AuNPs results in increased silver deposition 
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in the testing zone, leading to an intense color change. Figure 31B shows the key value 
with respect to concentration of protein. It can be seen that with increasing protein 
concentration, K value increases. The measure of K value can be used for a quantitative 
estimation of the arboviral envelope protein concentration present in the sample. 
  The microfluidic device was also tested against sterile, mechanically-defibrinated 
calf blood and complete sheep se-rum spiked with the given ZIKV and CHIKV 
recombinant envelope proteins as surrogates for infected human blood/blood products. 
The results are represented as black key color (K) as a function of protein concentration 
(Figure 32). The testing showed a response to as low as 1 pM of the recombinant protein 
in PBS and 10 pM when tested against spiked 10% calf blood (diluted with working buffer) 
or sheep serum. In the case of undiluted (i.e., 100%) calf blood, a slight increase in K 
value was observed in the presence of 100 pM (~5 ng/ml) of the protein. Diluting the blood 
with the binding buffer therefore increased the sensitivity of the system by ~10 fold. A 
comparative analysis of different detection techniques is shown in Table S1. The present 
sensor gives a minimum detection limit of 1 pM (50 pg/ml) for the ZIKV envelope protein 
and the CHIKV envelope protein E1 in PBS which is the lowest obtained so far. The 
similar detection limit (in buffer) was also obtained by Zeng et. al. using an antibody-
aptamer mediated sandwich assay on a 96-well ELISA plate[216]. The current approach 
abrogates the use of expensive plates or sophisticated plate reader making the device 
more adoptable in re-source constrained areas. 
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Figure 30: PDMS substrate for the detection of CHIKV protein 
 
 
Figure 31: (A) Digital image of the microfluidic channels representing color change in 
the testing zones in presence of different concentration of protein (1 pM, 10 pM, 100 
pM, 1 nM). The last two channels represent the specificity of the current sensor. The 
sample containing only ZIKV protein (10 nM) was introduced in the channel and no 
color change in the CHIKV region was observed and vice versa. This shows that the 
aptamers are highly specific in nature. (B) Graph represents the change in Key value 
(CMYK color model) calculated using ImageJ as a function of concentration of protein. 
Black and white are represented 100 and 0 respectively. It can be seen that the Key 
value moves towards black attributing to the increased deposition of Silver in the testing 
zone. 
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Table 3: Comparative analysis of different techniques used to detect the presence of 
Zika infection. 
Analyte Method 
Limit of 
Detection 
Detection Mode Reference 
Zika RNA RT-RPA 5 PFU/mL Mobile phone [190] 
Zika RNA RT-LAMP 50 PFU/ml 
Naked eye- 
Colorimetric 
[186] 
Zika NS1 ELISA 
0.1 ng/ml (2 
pM) 
UV absorbance- 
Colorimetric 
[216] 
NS1 
(flaviviruses) 
Impedimetric 
3 ng/mL, 30 
ng/mL 
Potentiostat [217] 
NS1 
(flaviviruses) 
Capacitance 
0.2 ng/mL, 
0.5 ng/mL 
Potentiostat [217] 
E protein 
(ZIKV) 
Chemiluminescence 10 PFU/mL 
Electro-generated 
chemiluminescence 
instrument 
[218] 
Zika NS1 
protein- 
Commercially 
available ELISA kits 
0.1 ng/ml 
UV absorbance- 
Colorimetric 
[219] [220] 
Zika, 
Chikungunya 
Nanoparticle 
immunoassay 
50 pg/ml (1 
pM) 
Naked eye-
Colorimetric 
Current 
work 
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Figure 32: Development of silver in the microfluidic channels as a function of different 
concentration of ZIKV and CHIKV envelop proteins (1 pM, 10 pM and 100 pM) has been 
represented in terms of Key value (CMYK color code). No change in K values for calf 
blood and sheep serum was observed in the presence of 1 pM of the protein. Serum 
and 10% calf blood exhibited a slight color development at 10 pM of the recombinant 
protein. In case of 100 pM, distinct color development was observed in all the three 
cases. 
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4.4 Summary 
In summary, a multiplex detection system for ZIKV and CHIKV arboviral envelope 
proteins has been developed using an aptamer-conjugated microfluidic channel 
approach. This novel method implements the immobilizing aptamers to the PDMS 
substrate using PMPI as the linker molecule. The channels are patterned with microsized 
pillars that facilitate an enhanced sensitivity of the approach down to detections of 1 pM 
(50 pg/ml) of viral envelope protein targets in PBS and 10 pM in dilute (10%) 
mechanically-defibrinated calf blood. The detection is based on a silver-enhancement 
technique that deposits a thick silver shell over the surface of target-bound Apt-AuNPs. 
This enhancement enables significant color changes on the PDMS substrate indicating 
the presence of target protein. The device also exhibited high specificity towards target 
protein with no interference from other, off-target arboviral proteins. The use of aptamers 
as the biorecognition molecule provides flexibility to incorporate additional or alternative 
targets by designing the specific aptamers and immobilizing them in the microfluidic 
channel. The present approach can be extended to detect other clinically important 
biomarkers for which there are few POC options available. 
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CHAPTER 5: CONCLUSIONS 
The present work successfully exhibited the development of unique biosensors detecting 
small biomolecules as well as viral protein such as Zika. These approaches provide a 
real-time detection of a large range of biomolecules and viral proteins in a time and cost-
effective manner and has applications in point-of-care testing tool for several diagnostics. 
In the first chapter, colorimetric detection of epinephrine molecules has been 
demonstrated using a simple paper based substrate. Epinephrine is an excitatory 
neurotransmitter which plays an important role in the functioning of different biological 
reactions. The present sensor utilized aptamers functionalized gold nanoparticles as the 
colorimetric probes to induce a color change (red to blue) in the solution in the presence 
of epinephrine molecule. The study also investigated role of different parameters such as 
morphology of AuNPs (size and shape), aptamer concentration and salt destabilization 
to achieve a highly sensitive and selective biosensor. It was observed that the size and 
shape of the gold nanoparticles played most important role in controlling the detection 
limit of the sensor. The sensor exhibited a detection limit of 900 pM for epinephrine giving 
colorimetric signal which has not been achieved in any other study till date.  
The second chapter emphasizes on the detection of epinephrine using a 
PEDOT:PSS based organic electrochemical transistor platform. The Au gate electrode 
was functionalized using epinephrine binding aptamers which acts as transducer. In the 
presence of epinephrine molecule, a significant decrease in the channel current was 
observed in the transfer characteristics as well as chronoamperometric measurements. 
This effect is attributed to the screening of the negative charge of aptamers and oxidation 
of epinephrine which increases the effective gate voltage resulting in a decrease in 
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current. The device was found to be highly sensitive towards epinephrine with a limit of 
detection of 90 pM which is less than the normal physiological range in humans (120 pM). 
Also, the device did not show any response towards common interfering agents such as 
dopamine, ascorbic acid, DOPAC etc. The approach provides a platform for the real-time 
detection of large range of biomolecules and viral proteins in a timely and efficient 
manner.  
 In the third chapter, the development of an aptamer based microfluidic sensor to 
detect multiple viral proteins has been shown. The working principle of the sensor is 
based on the formation of sandwich type morphology among aptamer-analyte-aptamer-
gold which induces color change visible to naked eye. Silver reagent has been used to 
enhance the color change. The sensor showed high affinity towards zika and CHIKV 
protein and no interference was observed by control sample. The colorimetric detection 
limit of the sensor has been found to be 1 pM (50 pg/ml) of viral envelope protein targets 
in PBS and 10 pM in dilute (10%) mechanically-defibrinated calf blood which is relevant 
to the practical applications. The use of microfluidic channel enables multiplex detection, 
integrates the whole system and reduces the complexity of the assay. The current sensor 
provides rapid, easy and cheap sensing technique with high sensitivity and selectivity, 
leading to a more consumer driven health care. 
The major advantage of employing aptasensors is that it can be designed for a 
large number of analyte molecules which offers a great potential to be applied in the fields 
of bioassay, biomedical diagnostic or environmental monitoring. The current work 
presents a set of tool box which provides a multiplex detection system for different viral 
proteins and show huge potential to be used in real world applications. Successful 
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implementation of these current sensors provides a means to a highly efficient, low cost, 
rapid and easy-to-use point of care diagnostic tools. 
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